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ABSTRACT
REGULATION OF BIOFILM AND ANTIBIOTIC-RESISTANCE BY THE
MODULATOR OF SarA (MSA) IN STAPHYLOCOCCUS AUREUS
by Antony Schwartz
December 2010
Staphylococcus aureus is an important human pathogen that is the causative agent
of life-threatening diseases such as endocarditis and osteomyelitis. The ability of S.
aureus to thrive as a successful pathogen can be partially attributed to its ability to form
biofilm. Biofilm is an extracellular polysaccharide, protein, and DNA-based slime layer
that protects the bacterial community. The global regulator sarA is essential for biofilm
formation. Since the modulator of sarA (msa) gene regulates several virulence factors and
is required for the full expression of sarA, the capacity of the msa mutant to form a
biofilm was examined. The mutation of msa results in reduced expression of sarA, and
the msa mutant formed a weak and unstable biofilm. The msa mutant is able to adhere to
surfaces and begins to form biofilm, but fails to mature indicating that the defect of the
msa mutant biofilm is in the accumulation stage but not in primary adhesion. This finding
is significant because it identifies a new gene that plays a role in the development of
biofilm.
Antibiotic resistance in Staphylococcus aureus has become an issue of paramount
importance as the rate of MRSA (Methicillin-Resistant Staphylococcus aureus)-related
deaths have surpassed HIV-related deaths in the United States over the last decade. In
this study, mutation of the msa gene leads to increased susceptibility (MIC 3 ȝg/ml) to
oxacillin in comparison to wild type MRSA strain COL (MIC 1600 ȝg/ml). RT-qPCR
ii

analysis was utilized to identify the genes that were differentially expressed. Apart from
the fem genes, genes such as aux14, sigB, mecA, murAB and mraY were all differentially
expressed in the msa mutant in comparison to the wild type strain COL. Additional
functional assays and TEM studies show that the bacterial cell wall is compromised upon
mutation of msa. The results from this study collectively indicated that msa plays an
important role in antibiotic resistance by regulating cell wall and cell wall-precursor
synthesis. Given these results and the possibility that Msa is a membrane protein, it is
possible that Msa could serve as a target for therapeutic agents designed against
Staphylococcus aureus.
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CHAPTER I
INTRODUCTION
Staphylococcus aureus: A Formidable Opponent
Identification, Morphology, and Colonization
Staphylococcus aureus is a Gram-positive eubacterium species that belongs to the
phylum Firmicutes, class Bacilli, order Bacillales, family Staphylococcaceae and genus
Staphylococcus. S. aureus is an important human pathogen that was the number one
cause of nosocomial infections in the U.S. with 19,000 deaths in 2005—more than the
number of deaths caused by HIV (78). Tremendous amount of resources have been
devoted to understand the molecular and genetic factors that provide this pathogen with a
clear advantage over the countless control and treatment measures devised through
modern technology. It is clear that an in-depth understanding of S. aureus—from the in
vivo pathogen population level to the molecular basis of host-pathogen interaction to the
complex global regulatory networks—is necessary to successfully mitigate the medical,
social and financial burden caused by this versatile and deadly bacterium.
In 1878, Robert Koch observed the presence of Gram-positive cocci with the
manifestation of various diseases. However, not until 1882 did Sir Alexander Ogston, a
Scottish surgeon, named the organism as Staphylococcus. This was based on his previous
observations in 1880 that a “cluster forming cocci” was the cause of abscess in humans.
In deed, Staphylococcus aureus gets its name from the Greek word staphyle, which
means bunch of grapes and coccus which means grain or berry (Figure 1.1). In 1884,
Rosenbach differentiated Staphylococcus aureus from other cocci on the basis of colony
pigmentation. The more virulent species formed colonies with a golden pigment (thus the
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name aureus, a derivative of the Latin word ‘aurum,’ which means gold), whereas the
less virulent species formed white colonies.

Figure 1.1. Representative images of Staphylococcus aureus as visualized with different
microscopy techniques. Characteristic clumping behavior is evident in these images.
SEM image (right) photo credit: Janice Carr, Centers for Disease Control and Prevention.
Staphylococci are 0.7-1.2 ȝm in diameter, growing most rapidly under aerobic
conditions in the presence of CO2. However, S. aureus is also capable of survival in
environments with very low concentrations of oxygen as well (for example, growth
within a biofilm) (33). The versatility of the pathogen is evident in the fact that
staphylococci can also tolerate high amounts of salt in the growth medium (from 7.5-10%
of NaCl) (57). Additionally, staphylococci can grow in a wide pH range (4.8 to 9.4) and
even at very high temperatures (60°C for a short duration).
Colonization with S. aureus occurs during the childhood years and is carried
throughout one’s life. S. aureus is primarily found in relative abundance in the anterior
nares, the throat and the perineum (red squares in Figure 1.2). Other secondary sites of
prevalence include the hands, the gastrointestinal tract, the vagina and the axillae (blue
circles in Figure 1.2). The fact that S. aureus is present in the nasal passage of 32.4% of
individuals in the U.S. population (55), combined with the increasing prevalence of
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Methicillin-Resistant Staphylococcus aureus (MRSA) strains world-wide (77, 114),
makes S. aureus a formidable pathogen that confounds healthcare workers and
researchers alike. In fact, the rate of hospital-acquired staphylococcal infections caused
by MRSA strains rose from 2% in 1974 to 64% in 2004, resulting in 126,000
hospitalizations in the U.S. (85) and S. aureus-related aggregate healthcare costs up to 1
billion dollars (110). The problem has been compounded further with a steady rise in
outpatient cases manifesting MRSA infections. (142) With community-acquired MRSA
infections (CA-MRSA) rapidly catching up with the more expected and somewhat
understood hospital-acquired MRSA infections (HA-MRSA) (139), it is imperative that
new therapeutic solutions are found for this rapidly evolving pathogen.

Figure 1.2. Staphylococcus aureus primary and secondary colonization sites.
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Infections Caused by S. aureus
Staphylococcus aureus is a multifaceted pathogen that can cause a wide array of
infections that range from the common skin abscesses to the more serious and lifethreatening conditions such as endocarditis (inflammation arising from vegetative
colonization of the heart valve tissue) and osteomyelitis (infections of the bone) (92).
Other serious life-threatening conditions caused by S. aureus include but are not limited
to Staphylococcus aureus bacteremia (SAB) (156), Staphylococcus aureus infective
endocarditis (SAIE) (46), surgical-site infections (1), device-related infections (implants,
catheters, etc.) (2), skin and soft tissue infections (100), spine and brain abscesses (131),
ocular diseases (6), staphylococcal pneumonia (80), urinary tract infections (153), toxic
shock syndrome and toxin-mediated syndromes (37, 92) (Figure 1.3). S. aureus is able to
cause these infections by successfully utilizing a plethora of virulence factors. These
virulence factors (potential therapeutic targets) are often redundant and/or variable across
different strains, making it even harder to formulate effective prophylactic or
immunological therapies. However, steady strides are being made in understanding the
molecular basis of staphylococcal infections that will help toward development of
vaccines and antibiotics against S. aureus.
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Figure 1.3. Staphylococcus aureus can cause a wide array of infections at various sites on
the human body. It can range from skin abscesses to life-threatening infections such as
endocarditis (Figure 1.4, Panel A) and osteomyelitis (Figure 1.4, Panel B).

Figure 1.4. Representative images of staphylococcal infections leading to A. Infective
Endocarditis1 and B. Osteomyelitis2. Heart and bone tissue have been degraded due to the
infection.
1
2

Image Credit: Michigan State University, College of Veterinary Medicine. Web link:http://cvm.msu.edu/pare/Docs/endocarditisB.jpg
Image Credit: University of Szeged, School of Medicine. Web link: http://www.szote.u-szeged.hu/radio/csont/csont5c.gif
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Antibiotic Resistance in Staphylococci
Methicillin-Resistant Staphylococcus aureus (MRSA)
Treating staphylococcal infections have become increasingly difficult owing to
the sharp increase in MRSA strains over the last few decades. As stated earlier, rise in
CA-MRSA cases, especially, are of great concern because these types of infections are
manifested in younger, otherwise healthy individuals who have not been recently
hospitalized. CA-MRSA strains generally cause skin and soft-tissue infections spreading
from skin-to-skin contact with infected individuals. Interestingly, HA-MRSA is resistant
to multiple types of antibiotics whereas CA-MRSA is typically highly resistant only to ȕlactams and a few other classes of antibiotics (109).
This antibiotic profile is partly due to the presence of various resistance genes that
are located in the mobile genetic element called staphylococcal cassette chromosome mec
(SCCmec). The SCCmec carries the mecA gene that encodes for the alternate penicillinbinding protein 2a (PBP2a). Apart from mecA, its regulatory genes (mecR1 and mecI)
and other insertion sequences are generally found on the SCCmec. (65). To date there are
VIII SCCmec types that range from 21 kb to more than 64 kb (81, 162) (Figure 1.5). With
a considerable degree of variability between the SCCmec types, the origin of this mobile
genetic element is still unclear. It is postulated that S. aureus could have possibly
obtained SCCmec from S. epidermidis via horizontal gene transfer (5, 61). Whatever the
origins may be, SCCmec, along with other mechanisms, confers S. aureus with the
invincibility to resist most antibiotics available today. Additional details regarding
antibiotic resistance mechanisms in S. aureus are discussed in Chapter IV.
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Figure 1.5. Schematic of SCCmec types identified thus far in Methicillin Resistant
Staphylococcus aureus. All types share the common mecA element but contain varying
combinations of Tn (transposon) and IS (insertion sequences) elements, and HighlyVariable Regions (HVR).
Staphylococci and Biofilm
Biofilm and Antibiotic Resistance
The ability of S. aureus to resist antibiotics is further intensified by the fact that it
takes 10 to 1000 times more antibiotics to inhibit the growth of cells within a biofilm
(67). Biofilm is a self-produced extracellular polysaccharide, protein and eDNA matrix
(62, 122, 140) that encloses the bacterial community and provides it with protection from
environmental factors and antibiotics (140). As a result of this protection, S. aureus in a
biofilm is exposed to sub-inhibitory concentrations of the antibiotic that not only helps in
promoting antibiotic resistance but also induces biofilm formation (66). In addition to the
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physical barrier provided by the biofilm, it has been proposed that cells growing within a
biofilm are resistant to antibiotics due to the fact that these cells grow slower in
comparison to exponential-phase bacteria in a planktonic growth condition (4). This
notion is further strengthened by studies that have shown that biofilm is more resistant to
beta-lactam antibiotics in comparison to other non-cell wall targeting antibiotics such as
minocycline and tigecycline (104). Beta-lactam activity is dependent on a rapidly
growing cell population with an active cell-wall turnover.
Of all growth conditions and physiological states studied, probably the most
clinically significant is staphylococci growth within a biofilm. Bacteria in biofilms
exhibit recalcitrance to antimicrobial compounds and persistence in spite of sustained
host defenses (59). Several factors can induce biofilm formation. Exposure to fluctuations
in glucose availability, osmotic stress, ethanol and certain antibiotics can all trigger
differential gene expression that leads to the bacterial community switching from a
planktonic state of growth to a biofilm state of growth (11, 88, 124). Staphylococcal
biofilms form generally in three distinct stages (Figure 1.6.): (1) primary adhesion to
surfaces by means of adhesins or cell wall components, (2) accumulation of multilayered
clusters of cells via the production of a polysaccharide, and (3) detachment and
dispersion of cells from the biofilm community (141).

Figure 1.6. Stages of Biofilm Formation. Source: Image adapted from Center for Biofilm
Engineering website: biofilm.montana.edu
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If biofilm formation and maintenance is in fact a highly regulated process, as
evidenced by the existing data in the literature and conclusions drawn by experts in the
field, it is imperative that a solid communication system should exist in order to precisely
coordinate the expression of various genes in response to environmental or genetic
signals. Staphylococci effectively employ such a system called quorum sensing based on
cell density in its immediate environment.
Quorum sensing is achieved by detecting chemical signals (autoinducing
peptides) produced and secreted by the cells in the vicinity. When the cell density
exceeds past a certain threshold, the cells are able to “perceive” the quantitative build-up
of neighboring cells and initiate changes in gene expression. Quorum sensing was first
observed in 1993 in Vibrio fischeri (8) and since then has been shown to be prevalent
among various Gram-positive and Gram-negative bacterium as a mode of inter-species
and intra-species communication (7, 48). Staphylococci possess two quorum-sensing
systems that have been studied extensively (82). The agr system, which along with the
Staphylococcal accessory regulator (sar) are major players involved in global gene
regulation in Staphylococcus aureus. Understanding the current knowledge regarding
these two systems will help understand how they possibly interact with the msa
(modulator of sarA) gene.
Global Regulators: Agr and SarA
Accessory Gene Regulator (agr) System
The agr quorum sensing system (Figure 1.7.), which is also responsible for
regulating virulence, is made up of two divergent promoters, P2 and P3 that encode for
RNAII and RNAIII, respectively. The RNAII transcript includes the agrACDB locus
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which encodes for an autoinducing peptide (AIP) that is secreted to the outside
environment and is sensed by a response regulator system that directly acts to control the
expression of various genes at the transcriptional level. Specifically, AgrA and AgrC
make up the response regulator and membrane sensor, respectively. AgrC detects the AIP
that is encoded by agrD. AgrB, which is embedded in the membrane, processes and
exports the AIP outside of the cell. The sensing of AIP by AgrC sets in motion a set of
phosphorylation events that activates the AgrA response regulator and induces
transcription from both P2 and P3 promoters. There are four different types of agr locus,
categorized based on the ability of AIP from one group to activate or inhibit AgrC from
another group (74, 75). AIP from S. epidermidis strongly inhibits S. aureus AgrC
belonging to agr type I, II and III, but not type IV. In contrast to healthy individuals,
where agr locus type distribution is relatively even, patients with chronic wounds or indwelling devices, agr locus type I is the most commonly seen group (52). It is possible
that one type of agr locus might interfere with other agr sensing systems to give itself a
competitive edge during pathogenesis.
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Figure 1.7. Schematic of the Agr quorum sensing system involved in virulence
regulation.

The RNAIII transcript, transcribed from the P3 promoter, spans the hld gene,
which encodes for the į-toxin (73). The agr system’s regulatory effects via the RNAIII
transcript is functional regardless of the production of į-toxin (72, 112, 154).The
regulation of virulence factor expression by the Agr system has been extensively studied
in vitro. RNAIII upregulates the production of the Į-toxin (Hla) (105) and downregulates
the production of surface protein A (Spa). RNAIII also indirectly regulates the production
of virulence factors through its action on other regulators such as rot (repressor of toxins)
(128). The overall regulatory effect of RNAIII is characterized by the increased
production of exoproteins (hla, hlb, hld, hlgCB, tst, sspABC, splABDF, aur, scp, seb, sec,
sed, eta, etb, geh, plc, lip, nuc, sak, cap, fame, scn, lukPV) and decreased production of
surface-associated proteins (111, 119).
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Expression of agr has also been associated with a reduced capacity to form a
biofilm in both S. aureus and S. epidermidis (53, 82). Strains that produced high levels of
RNAIII, such as RN6390, show an increase in biofilm when agr is mutated (10). It is
believed that the negative effect of agr on biofilm is most likely due to the surfactant
effects of the į-toxin encoded by the hld gene and not RNAIII itself (151). This is
supported by the observation made by Yarwood et al. (160) that agr might be part of a
dispersal system during the detachment stage of biofilm formation. Although mutation of
agr increases biofilm in vitro, several studies in animal models have shown that agr
mutant in vivo has reduced virulence (3, 16, 23, 51, 98, 102). Given that in vivo
conditions could expose the agr mutant to several host- or infection-specific variables; it
is possible to envision a sophisticated agr system that regulates the expression of genes
necessary for biofilm formation and virulence depending on the situation at hand. In fact,
studies comparing CA-MRSA and HA-MRSA strains have shown that there is an
increased level of agr in the former (154). Additionally, there was an increase in the
production on phenol-soluble modulins (PSMs), which are positively regulated by agr
and have been attributed as the reason for increased virulence seen with CA-MRSA
strains (154). PSMs, a total of seven in S. aureus, function as chemoattractants and have
proinflammatory properties (87, 114). Mutation of PSMs, although not all, have led to
decreased virulence in a murine bacteremia model (154). Collectively, this indicates that
the agr system may be controlling the expression of two distinct phenotypes in vivo—
biofilm formation and toxin production—each, proving to be advantageous at the
appropriate time.
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Staphylococcal accessory regulator A (sarA)
The agr system, apart from autoinduction, is controlled by several other
regulatory factors that modulate the expression of virulence gene either through agr or
independent of agr. One such gene that was discovered in 1992 is the Staphylococcal
accessory regulator (sar; later renamed to sarA as more homologues were discovered)
(24). SarA has been shown to bind the intergenic region between the agr P2 and P3
promoters (26, 63, 106, 123). It is believed that SarA binding activates the transcription
of agr and that this accounts in large part for the impact of sarA on expression of S.
aureus virulence factors. Mutation of sarA in the 8325-4 strain RN450 and RN6390 was
found to limit expression of agr and a number of agr-regulated genes, particularly under
microaerophilic growth conditions (22, 27).
The sarA locus encodes three overlapping transcripts, all which share a common
terminus and include the sarA gene (9). These transcripts have been designated sarA
(0.56 kb), sarC (0.8 kb), and sarB (1.2 kb), with the corresponding promoters designated
P1, P2 and P3, respectively (97). The sarA and sarB transcripts are produced
preferentially during the exponential growth phase while the sarC transcript is produced
preferentially during the post-exponential growth phase (97).
SarA and its homologs are dimeric winged helix DNA-binding proteins. Each of
the monomers contain five Į-helices, three ȕ-strands and several loops (Į1Į2-ȕ1Į3Į4ȕ2ȕ3-Į5). Within each winged helix motif is a helix-turn-helix motif (bold) and a ȕhairpin turn wing (underlined), both of which are putative DNA binding domains. SarA
and its homologs (n = 11) belong to the SarA protein family. Within this grouping, these
proteins are further divided into 3 sub-families: 1. single-domain proteins, 2. two-domain
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proteins and 3. MarR homologs (25). SarS, SarY and SarU belong to the two-domain
protein sub-family; SarA, SarR, SarV, SarT, SarX and Rot belong to the single-domain
sub-family; and SarZ and MgrA belong to the MarR homolog sub-family. These proteins
and their functions have been summarized in Table 1.1. Several mechanisms of
regulation by the SarA protein family have been proposed (25), however, from the
protein structure studies performed by Liu et al., (90) the initial steps of regulation appear
to be established when the major groove of the target DNA is bound by the helix-turnhelix region and the minor groove is bound by the winged region.
Genomic DNA analysis has shown that these SarA homologs are also present in
other clinically important Staphylococcus species such as S. epidermidis, S.
saprophyticus, and S. hemolyticus (25). Although the exact virulence genes and
mechanism might differ from species to species, the presence of these homologs is
significant in narrowing down meaningful targets for therapy.
Table 1.1
SarA Protein Family and Its Functions
Gene Locus
mgrA SA0641
rot
sarA
sarR
sarS
sarT
sarU
sarV
sarX
sarY
sarZ

SA1583
SA0573
SA2089
SA0108
SA2286
SA2287
SA2062
SA0623
SA2091
SA2174

Possible Function
MarR homolog; A regulator of autolysis and agr (also called rat or
norR)
A repressor of toxin synthesis, opposite to agr
Activates genes via agr and agr independent pathways
A negative regulator of sarA and positive activator of agr
An activator of protein A synthesis
An activator of sarS and a repressor of alpha hemolysin synthesis
A positive regulator of agr
A regulator of autolysis repressed by SarA and MgrA
A negative regulator of agr and activated by MgrA
Function Unknown
MarR homolog; A positive regulator of hla
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SarA is necessary for the transcription of the ica operon, but it is not known
whether it directly or indirectly activates ica transcription since the typical SarA binding
sequence upstream of virulence genes is not found upstream of ica (60, 150). The
staphylococcal accessory regulator, sarA, is a major global regulator that is essential for
biofilm formation both in vitro and in vivo (10, 150). Additionally, O'Neill et al. (113)
showed that sarA is essential for biofilm formation in both MRSA and MSSA. However
the mechanism of sarA regulation of biofilm is not yet understood.
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CHAPTER II
BACKGROUND RELEVANT TO THIS STUDY
The Modulator of SarA (msa) Gene
Msa Regulates Expression of SarA
In 2006, Sambanthamoorthy et al. (130) showed that the msa (modulator of sarA)
gene regulates the expression of various virulence factors either through sarA or
independently of sarA. As stated earlier, SarA is a global regulator that controls the
expression of over 100 virulence genes and other cellular processes. However, evidence
from previous studies suggested that there may exist accessory elements that control the
expression of sarA and/or the function of SarA. For example, the mutation of sarA
decreased the expression of agr but in an in vitro transcription system, purified SarA
inhibited transcription from agr promoters (21). Also, SarA regulates gene expression in
a temporal manner but SarA is present approximately at the same amounts throughout the
growth cycle (15, 28, 97). This indicated the presence of an additional element(s) that is
present within growing cells that augments SarA regulation. Indeed, these observations
lead to the development of a luminescent reporter system (cna-luxABCDE) to screen for
sarA-related defects in mutants generated by transposon mutagenesis in the RN6390
background (130). Mutants that showed a sarA-mutant-phenotype in a sarA-positive
genotype were selected for further characterization. It was reported that the msa gene
(SA1233) positively modulates the expression of sarA and regulates the expression of
several virulence genes (130).
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Figure 2.1. Msa regulates virulence factors via SarA or independent of SarA.

Msa Regulates Several Virulence Factors
Sambanthamoorthy et al. (130) have performed various phenotypic
characterizations in order to fully understand the role of msa in S. aureus. Protease assay
with the msa mutant showed an increase in proteolytic activity, similar to that of a sarA
mutant in previous studies (14). Complementation with a good copy of msa on a plasmid
vector restored protease levels back to wild type amounts. Hemolytic activity on the other
hand was reduced in the msa mutant. Hemolytic activity was measured from postexponential growth phase (12 h) by using 1 % rabbit blood. Total hemolytic activity was
reported as the percentage of activity relative to the parent strain, RN6390. Regulatory
mutants sarA, agr and sarA/agr were included as controls. sarA mutant behaved similarly
to that of the msa mutant.
When tested for its ability to bind to host proteins, the msa mutant was unable to
bind to fibronectin and fibrinogen. Results of fibronectin binding were consistent with the
transcription studies done where fnbA expression was down in the msa mutant. However,
clfA expression (virtually unchanged in comparison to wild type) did not correlate with
the results from the fibrinogen-binding assay. The authors attributed this decrease in
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fibrinogen-binding capacity to the increase in protease levels, as reported earlier by
McAleese et al. (99). Mutation of msa enabled RN6390 to bind to collagen. Since
RN6390 does not have the cna gene, strain UAMS-174 (a derivative of RN6390 with the
cna gene inserted in the chromosome) was used for this assay. Complementation with a
functional copy of msa restored collagen-binding to wild type levels.
Msa, a Membrane Protein?
Finally, sequence analysis of Msa indicated that it is a membrane protein with
three transmembrane domains that contained phosphorylation and binding sites, which,
suggests that Msa might interact with the external environment (108) (Figure 2.2). The
authors of the study hypothesized that Msa acts as a sensor for an external signal that
modulates sarA expression and thereby regulates the expression of S. aureus virulence
factor (130). It should also be noted that according to this study, Msa appears to be highly
conserved among different strains (RF122, MRSA252, MSSA476, MW2, COL, Mu50,
N315, and NCTC 8325) of S. aureus based on both nucleotide and protein sequences
(108). However, the authors were unable to find any known homologous proteins with
high degree of significance, thus, making Msa a putative novel signal transducer protein.
Studies are currently underway to validate the predicted Msa protein structure.
Given the exciting possibility that Msa could be an unique interface between
external signals and internal gene regulatory networks, the role of msa in cellular
processes and global gene regulation was studied to gain further understanding into the
previous findings that Msa regulates several genes either through sarA or independent of
sarA (130).
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Figure 2.2. Schematic of predicted Msa protein structure depicting three transmembrane
domains, possible phosphorylation sites and signal peptide cleavage site. Adapted from
Nagarajan et al. (108).
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CHAPTER III
MSA IS INVOLVED IN THE ACCUMULATION STAGE OF BIOFILM
FORMATION IN STAPHYLOCOCCUS AUREUS
Abstract
Staphylococcus aureus is an important pathogen that forms biofilm. The global
regulator sarA is essential for biofilm formation. Since the modulator of sarA (msa) is
required for full expression of sarA and regulates several virulence factors, the capacity
of the msa mutant to form a biofilm was examined. The mutation of msa results in
reduced expression of sarA in biofilm and that the msa mutant formed a weak and
unstable biofilm. The msa mutant is able to adhere to surfaces and begins to form biofilm
but fails to mature indicating that the defect of the msa mutant biofilm is in the
accumulation stage but not in primary adhesion. The msa gene plays an important role in
biofilm development which is likely due to its role in modulating the expression of sarA.
This finding is significant because it identifies a new gene that plays a role in the
development of biofilm.
Introduction
Staphylococcus aureus is a gram-positive pathogen that causes potentially life
threatening nosocomial- and community-acquired infections, such as osteomyelitis and
endocarditis. An important characteristic of S. aureus is its ability to form a biofilm, a
characteristic associated with several diseases (41). Bacteria in biofilm are encased in a
polysaccharide glycocalyx (140), which provides them with protection against host
defenses and antimicrobial drugs (140). Staphylococcal biofilm form in two distinct
stages: (1) primary adhesion to surfaces by means of adhesins or cell wall components,
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and (2) accumulation of multilayered clusters of cells via the production of a
polysaccharide (32). Cells are also able to detach from the biofilm and disperse to distant
sites for colonization or infection. Various genetic factors are also involved in regulating
biofilm formation, maintenance and dissemination. Although much is known today, the
mechanisms underlying complex regulatory networks that fine-tune the biofilm
phenotype are yet to be uncovered by the research community.
Biofilm Genetics
There are various genetic factors that regulate the expression of genes necessary
to initiate and sustain a biofilm state of growth. The irreversible adherence of freefloating planktonic cells to a to host tissue or other surfaces is facilitated by surface
adhesins called microbial surface components recognizing adhesive matrix molecules
(MSCRAMMs) (45). The MSCRAMMs are made up of the collagen-binding protein
Cna, Fibronectin-binding proteins, FnbA and FnbB, and the fibrinogen-binding proteins
clumping factor A and clumping factor B, ClfA and ClfB. These molecules bind to
collagen, fibronectin and fibrinogen in the host tissue (45). Once the cells get established
over a surface, intercellular adhesins such as poly-N-acetylglucosamine (PNAG), S.
aureus surface protein G (SasG), accumulation and adhesion-associated protein (Aap)
and biofilm-associated protein (Bap) are expressed in order to facilitate cell-to-cell
adhesion and maturation of the biofilm (30, 93, 96, 126). Transcription of these genes and
biofilm formation in response to environmental or genetic cues is controlled by global
regulators such as SarA, SigB, MgrA (60, 123, 145) and other as-of-yet unidentified or
uncharacterized factors. Although a lot of research has been conducted to understand the
components of a biofilm and the regulators that sculpt its formation and dissemination,
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we have only scratched the surface in understanding this complex mode of growth
coordinated by the bacterial community.
The ica locus, which encodes for IcaA, IcaC, IcaD and IcaB, is one of the well
studied biofilm components that is necessary for the synthesis of PIA/PNAG in S. aureus
and S. epidermidis. The membrane protein IcaA together with IcaD (to achieve maximum
enzyme efficiency) function as an N-acetyglucosaminyltransferase to catalyze the
production of 10-20mers of N-acetylglucosamine from UDP-N-acetylglucosamine. Nacetylglucosamine oligomers longer than 20-mer are synthesized and exported out of the
cell with the help of IcaC (54, 56). Outside the cell, IcaB, a secreted protein, acts as a
deacetylase that optimally (approximately 2-8%) deacetylates amino acid groups from the
synthesized oligomer which aids in bacterial aggregation and biofilm formation (96). The
icaADBC operon is negatively regulated by the transcriptional repressor protein IcaR
(intercellular adhesin regulator).
In 2007, Rohde et al. (127), showed that factors other than polysaccharides were
involved in biofilm formation. Since then, proteinaceous biofilm adhesins such as Bap,
SasG, Aap, and AtlE (an autolysin) have all been shown to play a role in the biofilm
phenotype. Of importance is the possibility that these proteins could be specific to
certain strain or even to certain staphylococci species. For example, Bap is a necessary
intercellular adhesin that has so far only been identified in bovine mastitis isolates and is
not implicated in isolates causing infections in humans (34). Another example is the Aap
protein, which has significant homology to the SasG protein, has been identified in S.
epidermidis strains (30, 134). AtlE, a 148 kDa protein, is involved in initial attachment
and accumulation during biofilm formation. Also, AtlE was implicated in the
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accumulation of extracellular DNA (eDNA). It is speculated that DNA might be released
by the autolytic action of AtlE and eDNA could possibly contribute to the stability in the
complex architecture of a mature biofilm (62, 122).
The staphylococcal accessory regulator sarA is a major global regulator that is
essential for biofilm formation both in vitro and in vivo (10, 11, 150). Beenken et al.
(2003) reported that the mutation of sarA reduced biofilm formation in six of the eight
clinical strains they tested (UAMS-1, UAMS-601, SA113, SC-01, S6C, and DB) (10).
Around the same time, a similar study by Valle et al., also found that SarA is essential for
biofilm formation in Staphylococcus aureus (150). Of interest, O'Neill et al. (113)
showed that sarA is essential for biofilm formation in both MRSA and MSSA. However
the mechanism of sarA regulation of biofilm is not yet understood.
Previously the msa gene was identified as a positive modulator of sarA (130). We
also showed that mutation of msa resulted in differential expression of several virulence
factors (130). These findings prompted the present study, focused on the role of msa in
biofilm formation. Based on these previous observation that sarA mutants in several
strains are unable to form a biofilm (10, 150), and the fact that msa modulates the
expression of sarA (130), the msa mutant’s capacity to form biofilm in MRSA strain
COL was tested. From various genetic and phenotypic evidence presented in this study, it
is proposed that the msa gene is indeed involved in modulating the accumulation of
biofilm in S. aureus.
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Materials and Methods
Bacterial Strains, Plasmids, and Growth Conditions
Biofilm-forming S. aureus strain COL was chosen for study because it forms a
biofilm in vitro and is virulent in animal models of endocarditis (71, 125). Strains were
grown on tryptic soy agar (TSA) or in tryptic soy broth (TSB) at 37°C under constant
aeration, supplemented with antibiotics whenever appropriate. The media used in flow
cells and microtiter plate assays were TSB supplemented with 3% sodium chloride and
0.5% glucose. These conditions have been shown previously to promote good biofilm
growth (10).
Phage Farming and Transduction
Generalized transduction with phage ĭ11 was utilized to generate an msa mutant
and a complemented msa mutant in the COL strain. A phage lysate was prepared by
overlaying TSA plates with TOP Agar (3 grams of TSB, 0.7 grams of Bacto™ Agar, 100
ml dH20, autoclaved and cooled to 50°C before use) containing 100ȝl of cells from a
moderately-thick (1/4th of a plate) suspension of the donor strain, 100ȝl of phage (10-fold
serial dilutions, from -1 to -5) and 40ȝl of 500mM CaCl2. The plates were incubated
overnight at room temperature. The next day, the plate with the least amount of phage
and the most clearing was harvested and the suspension was filter-sterilized using a
0.2ȝm filter. A 100ȝl aliquot was plated on a TSA plate to test for sterility of the lysate.
To perform the transduction, 500 ȝl of recipient-strain cells (from a very heavy
suspension; full plate of cells into 2ml of medium) was added to 500 ȝl of the prepared
phage lysate in 1ml of TSB containing 20 ȝl of 500 mM CaCl2. The mixture was then
incubated at 37°C with vigorous shaking for exactly 20 minutes. At the end of 20
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minutes, 1ml of ice-cold 0.02M sodium citrate was added and the tube was placed on ice.
Cell pellets were collected by centrifugation and the pellets were resuspended in 500 ȝl
of 0.02M sodium citrate before being plated onto TSA plates containing selective
medium and 500 ȝg/ml of sodium citrate. Colonies that appeared on these plates were restreaked and screened using PCR and/or restriction digestion.
Biofilm Assay
Biofilm assays were performed in microtiter plates and flow cells, as described
previously (10, 11), in order to study static biofilm conditions and biofilm conditions
under shear stress, respectively.
Microtiter plate biofilm assay. The biofilm forming capacity of the wild-type
COL strain, the msa mutant, and the complemented msa mutant were examined by
microtiter plate assay. A standard 96-well microtiter plate biofilm assay was conducted as
follow: Overnight cultures were diluted 1:200 into TSB supplemented with 0.5% glucose
and 3.0% sodium chloride. Samples (200 μl) were transferred into the wells of a 96-well
polystyrene microtiter plate (Corning, Inc., Corning, NY). These wells were pre-coated
for 24 h at 4°C with 20% human plasma diluted in carbonate buffer (pH 9.6). After
incubating the innoculated plates without shaking at 37°C for 24 h, the wells were gently
washed twice with 200 μl of phosphate-buffered saline to remove non-adherent cells.
Adherent biofilm were then fixed with 200 μl of 100% ethanol prior to staining for 2 min
with 200 μl of 0.41% (wt/vol) crystal violet in 12% ethanol (Protocol Crystal Violet;
Biochemical Sciences, Swedesboro, NJ). The stain was aspirated, and the wells were
washed three times with phosphate-buffered saline. A quantitative assessment of biofilm
formation was obtained by adding 100 μl of 100% ethanol and incubating at room
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temperature for 10 min. A total of 50 μl of the eluate was transferred to a sterile
polystyrene microtiter plate, and the absorbance at 595nm was determined using a
Synergy2™ Multi-Mode Microplate Reader (BioTek Instruments, Inc., Winooski, VT).
Flow-cell biofilm assay. The microtiter plate assay is a very quick and highthroughput way to screen for biofilm defects; however, due to the technically tedious
nature of this assay employing several washes with PBS, it was possible that the biofilm
could have been dislodged before staining. Therefore, in addition to the microtiter plate
assay, a more robust system of biofilm formation was used. Specifically, the flow-cell
biofilm device was used to study the role of msa in biofilm formation. Flow-cell device
(Stovall Life Sciences, Greensboro, NC) is a once-flow-through system that pumps a
constant flow of growth medium at a steady rate using a peristaltic pump over a 1mm x
1mm x 4mm plastic chamber where the biofilm growth occurs. This type of device
closely mimics the environmental conditions experienced by cells in a biofilm state of
growth.
The device was pre-coated with human plasma. A suspension of bacteria from an
overnight culture of the respective strains was then introduced into the flow cell channels
by injection and allowed to incubate at 37°C for one hour. Enriched media (TSB
containing 3% sodium chloride and 0.5% glucose) was pumped through the flow cells at
a flow rate of 0.5 ml/min. Flow cells were observed and photographed periodically. No
antibiotic selection was used when growing the complemented msa mutant in biofilm.
Adherence Assay
Two adherence assays were used to measure the capacity of the msa mutant to
bind surfaces with or without pre-coating with plasma.
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Microtitire plate assay. The first adherence assay was performed by modifying
the microtiter biofilm assay described above. Briefly, overnight cultures of S. aureus test
strains were diluted to an OD560 of 0.1 in fresh TSB, and 200 ȝl was added to each well
(polystyrene pre-coated with human plasma) in triplicate. Following one hour incubation
at 37°C, the microtiter wells were washed three times with 1X PBS. Adherent cells were
fixed with 200 ȝl of 100% ethanol for 10 min. Ethanol was discarded and the wells were
allowed to be air dried for 2 min. Adherent cells were then stained for 2 minutes with 200
ȝl of 0.41% Crystal Violet (w/v in 12% ethanol), then washed three times with 1X PBS.
Again, the wells were allowed to dry, and then ethanol was used to elute the crystal violet
from the wells. Absorbance readings were taken at 595 nm using a Synergy2™ MultiMode Microplate Reader (BioTek Instruments, Inc., Winooski, VT). An average of data
collected from three independent experiments is reported.
Catheter adherence assay. The second assay measures adherence to a catheter
without pre-coating with plasma. This assay was performed as previously described by
McKenny et al. (101). Briefly, staphylococcal strains were grown overnight in TSB and
cultures were standardized to an OD650 of 0.1. Catheters (PE10; Becton Dickinson and
Co., Sparks, MD), 0.5 cm in length were placed into appropriate cultures. After
incubating the cultures at 37°C for 30 min, the catheters were removed using sterile
forceps and washed five times in sterile PBS. After washing, the catheters were placed in
1% proteose peptone (Difco, Ann Arbor, MI) and continuously vortexed for two minutes
to release bacterial cells from the catheter. Serial dilutions were plated onto TSA plates in
order to enumerate the bacteria. The mean and standard errors were calculated for the
adherence of each strain.
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Confocal Microscopy
Confocal scanning laser microscopy was performed using a Carl-Zeiss LSM 510
META with excitation at 488 nm and emission collected at 500 to 530 nm (green
channel). Image stacks of the biofilm were taken from at least three distinct regions on
the flow cell and analyzed using the provided software (Carl-Zeiss, Inc., Peabody, MA).
Thickness of the biofilm was measured starting from the z-section at the flow-cell/biofilm
interface to the z-section at the top of the biofilm surface containing < 5% of total
biomass.
Cell Collection and RNA Isolation
Total RNA was isolated from S. aureus planktonic cultures using Qiagen RNeasy
Mini column (Qiagen) as previously described (130), based on a method developed by
Lindsay and Foster (89). S. aureus cultures were grown without antibiotic selection and
under low-aeration conditions (150 r.p.m. at a media volume:flask volume ratio of 0.5).
Cells were harvested at optical densities (OD560) of 0.3, 1.5 and 4.0, which correspond to
the mid-exponential, late-exponential, and post-exponential growth phases, respectively.
Isolation RNA from biofilms was accomplished by harvesting cells from flow cells as
previously described (10) and using Qiagen RNeasy Mini column. The optional oncolumn RNase-free DNase I (Qiagen) was used to remove contaminating DNA. After
isolation of RNA, traces of contaminating DNA were further eliminated by treating RNA
samples with RNase-free DNase I (DNA-free kit, Ambion) and incubating at 37°C for
20 min. Samples were used immediately or stored at –80°C. The quality, integrity and
concentration of the RNA were determined by using an Agilent 2100 Bioanalyzer
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(Agilent Technologies, Santa Clara, CA) as described by the manufacturer. An average of
data collected from three independent experiments is reported.
Real-Time Quantitative PCR
The primers that are used for real-time quantitative PCR (qPCR) were designed
with Primer3 software (Massachusetts Institute of Technology) to amplify gene fragments
with an optimal size of 75–100 bp. The fragment of the gene of interest was cloned into
plasmid pCR2.1 TOPO to determine PCR efficiency. Specifically, the plasmid was
isolated and a series of 10-fold dilutions were prepared corresponding to 500,000 to 5
plasmid copies. For each primer set, a standard curve was generated to determine the
correlation coefficient as an indicator of PCR efficiency. All RT-qPCR reactions were run
in triplicate. Melting curve analysis and agarose gel electrophoresis was done to verify
primer set specificity.
Measurements of relative levels of gene expression were done by RT-qPCR. Total
RNA was reverse transcribed into cDNA using iScript cDNA synthesis kit (Bio-Rad).
The reverse transcriptase reactions were done at 25°C for 5 min, 42°C for 30 min and
85°C for 5 min. cDNA was stored at –20°C until needed. PCR reactions were done in
25 μl reactions by using iQ SYBR Green Supermix (Bio-Rad) as recommended by the
manufacturer (Bio-Rad). The reaction mixtures contained: 5 μl cDNA; 12.5 μl iQ SYBR
Green Supermix; 0.5 μl forward primer (1.5 pmol μl–1); 0.5 μl reverse primer
(1.5 pmol μl–1); and 6.5 μl de-ionized H2O. PCR amplification was done using an iCycler
(Bio-Rad) and the amplification parameters were as follows: 94°C for 3 min, 1 cycle at
95°C for 3 min, 40 cycles at 95°C for 30 s, 50°C for 30 s and 72°C for 1 min. The final 80
cycles began at 55°C and were increased by 0.5°C every 10 s. All RT-qPCR reactions
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were done in triplicate and the mean CT was used for analysis of results. To verify the
absence of contaminating DNA, each RT-qPCR experiment included controls that lacked
template cDNA or reverse transcriptase. The constitutively expressed gene for gyrase
(gyr) was used as an endogenous control as described previously (54). Analysis of
expression of each gene was done based on at least two independent experiments.
Twofold or higher changes in gene expression were considered significant.
Results and Discussion
Prior studies have shown that the modulator of sarA gene (msa) is required for
full expression of sarA, which in turn is essential for biofilm formation (10, 130, 150). To
examine the role of msa in biofilm formation, a msa mutant was generated in the
methicillin-resistant S. aureus (MRSA) strain COL. S. aureus COL was chosen for study
because it forms a biofilm in vitro and is virulent in animal models of endocarditis (71,
125). The msa mutation was confirmed, and its effect on sarA, by measuring transcription
levels of msa and sarA in the wild-type COL strain, the msa mutant, and the
complemented msa mutant by real-time quantitative PCR (RT-qPCR). As expected, the
msa mutant showed no detectable expression of msa in planktonic cultures or biofilm
(Table 3.1). Additionally, transcription of sarA was reduced at least five-fold in these
cultures in both planktonic cultures and biofilm (Table 3.1). These results are consistent
with finding from the previous study (130) and show that msa is a positive modulator of
sarA during planktonic growth as well as biofilm in strain COL.
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Table 3.1
Relative Expression of msa and sarA in the msa Mutant
Biofilm
msa
vs.
COL
Gene

Function

Planktonic

Compl.
vs.
COL

msa vs. COL

mature (12 hrs)

Compl. vs. COL

mid

late

post

mid

late

post

msa

modulator of sarA

0.002

1.15

<0.001

<0.001

<0.001

0.95

0.57

0.88

sarA

Staphylococcal
accessory regulator A

0.30

0.77

0.22

0.21

0.12

0.76

0.78

0.48

Note. Gene expression of msa and sarA in the msa mutant or the complemented mutant (Compl.) relative to wild-type (COL). Values
represent the mean ratio of three independent experiments. Expression measurements were done in biofilm and three planktonic
growth phases (mid-exponential, late-exponential and post-exponential).

Reduced Biofilm Formation in the msa Mutant
Biofilm formation was observed at 6, 12, and 24 h post-inoculation in the wildtype COL strain and the complemented msa mutant microtiter plates. Conversely, there
was no evidence of biofilm formation for the msa mutant at 6 or 12 h post-inoculation
(Figure 3.1). At 24 hours post-inoculation, the msa mutant formed a biofilm that appeared
similar to that of the wild-type COL strain. These results were reproduced at least three
times and were confirmed in subsequent experiments, suggesting that the msa mutant has
a defect in biofilm growth under steady-state conditions.
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6h

24 h

12 h
COL

COL

msa-

msa-

Compl

Compl

Figure 3.1. Biofilm formation in the msa mutant in microtiter plates. The wild type strain
COL, the msa mutant and the complemented msa mutant were grown in TSB
supplemented with NaCl and glucose. Cultures were incubated for 6, 12 and 24 hours in
the wells of microtiter plates with pre-coating with plasma proteins. The violet staining is
an indication of biofilm formation in the wells.

Figure 3.2. Biofilm was quantified by staining with crystal violet and elution with
ethanol as described in Materials and Methods section. All values have been normalized
to wild type levels which were arbitrarily set as 100%.

msa Mutant has Defective Biofilm under Flow Conditions
The results in Figure 3.1. clearly show that the msa mutant forms a weak or
defective biofilm up to 12 hours post inoculation. To isolate the biofilm formation stage
at which the defect is manifested—initial attachment stage, cell-to-cell adhesion and
accumulation stage or the detachment stage—a flow-cell biofilm assay was performed.
Wild-type COL strain and the complemented msa mutant formed robust and mature
biofilms by 12 hours post-inoculation (Figure 3.3). The msa mutant, however, failed to
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form a robust and uniform biofilm within the flow cell in the first 12 hours (Figure 3.3).
The gross morphology of the partial biofilm formed by the msa mutant was similar to
those formed by the wild type strain and the complemented mutant (Figure 3.3).
However, while the biofilms formed by the wild-type and the complemented msa mutant
persisted for up to 36 h before sloughing off, the biofilm formed by the msa mutant
rapidly disintegrated (Figure 3.3). These results were confirmed in three independent
experiments, indicating that the msa mutant is defective in its ability to form mature
biofilms.

Figure 3.3. Biofilm formation in the msa mutant in flow cells. The wild type strain COL,
the msa mutant, and the complemented msa mutant were used to inoculate flow cells.
TSB supplemented with NaCl and glucose was provided at a flow rate of 0.5 ml/minute.
Biofilm formation was monitored for 36 hours. Arrow indicates the direction of flow of
medium.
msa Mutant Not Defective in Initial Attachment
Two different adherence assays were used in order to determine if the msa biofilm
defect was in the initial attachment stage of biofilm formation. A modified microtitre
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plate biofilm assay, where cells are incubated only for an hour, showed that the msa
mutant actually bound to the polystyrene surface at a significantly greater degree than the
wild type strain COL or the complemented msa mutant strain (Figure 3.4, Panel A).
Some strains of S. aureus require host proteins in order to adhere to the surface. In order
to rule out any bias in adherence due to the cells’ interactions with host proteins in the
human plasma, a catheter adherence assay was done without coating the catheters in
human plasma. Again, the msa mutant adhered to a greater degree to the catheters than
the wild type or the complemented msa mutant strains (Figure 3.4, Panel B).

Figure 3.4. The msa mutant adheres to surfaces better than wild type. A. Catheter
adherence assay done without human plasma. B. Modified microtitre-plate assay done
with human plasma.

35
msa Mutant Grows Normally But Does Not Accumulate within Biofilm
The possibility that the mutation of the msa gene causes a growth defect could
explain the weak biofilm phenotype. Growth rates were measured for the wild-type
strain, the msa mutant, and the complemented msa mutant in planktonic cultures in TSB.
All three strains grew equally under normal growth conditions (Figure 3.5).
Next, the rate of cell accumulation within the flow cell system was measured for
the wild-type and msa mutant strains. In order to monitor cell deposition, plasmid
pSB2019 (a constitutively expressed Gfp3a plasmid construct obtained from Dr. Phillip J.
Hill; (121)) was introduced into the wild type COL and COL msa mutant strains. A CarlZeiss LSM 510 META confocal laser scanning microscope with excitation at 488 nm and
emission collected at 500 to 530 nm (green channel) was used to monitor biofilm
formation at regular intervals. Consistent with the results from the adherence assays,
there was no significant difference in initial adherence to the surface or formation of
microcolonies between the msa mutant and the wild-type at 4 hours (Figure 3.6).
However, Z-stack images of the biofilm at 6 hours (Figure 3.6) showed that the msa
mutant cells were unable to accumulate and grow into a mature biofilm in comparison to
the wild type. The wild type strain COL on the other hand was able to form a mature
tower-like structure that is characteristic of a robust biofilm. This suggests that the msa
mutant has a defect in the accumulation stage of biofilm formation.
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Figure 3.5. Growth curve of the wild type strain COL, msa mutant and the complemented
msa mutant. The strains do not show any significant defects in growth.

Figure 3.6. Z-stack images of the biofilm using confocal microscopy. Both the wild type
strain COL and the msa mutant adhere to the flow-cell surface at 4 hours growth. At 6
hours of growth, the msa mutant biofilm is unable to form mature tower-like structures
(white arrow head) that are indicative of complex biofilm architecture.
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In addition to sarA, differential gene expression analysis of several other genes
known to be involved in biofilm formation was conducted using RT-qPCR. Fold change
in gene expression of all tested genes is listed in Table 3.2. A change in expression level
of twofold or higher was considered to be significant.
Table 3.2
Relative Gene Expression of Factors Involved in Biofilm Formation
Biofilm
Gene

Function

msa vs. COL

Compl. vs. COL

fnbA

fibronectin-binding protein

0.79

0.83

clfA

clumping factor A

0.16

0.68

atl

bifunctional autolysin

0.35

0.88

alsS

Į-acetolactate synthase

9.77

1.51

arcA

arginine deiminase

< 0.001

0.56

icaA

intercellular adhesin

0.72

2.06

spxA

transcriptional-regulator

0.72

1.16

tcaR

transcription regulator

1.12

0.76

Note. Genes known to be involved in biofilm formation and regulation were analyzed using RT-qPCR and their relative gene
expression values were calculated using the delta-delta Ct method. Values presented here are an average of two independent runs
comparing the msa mutant gene expression to the wild type strain COL and the complemented msa mutant is compared to the wild
type strain COL.

Some of these selected loci are regulated by sarA (alsS, atlA, and icaA); the others
are not directly associated with the sarA regulon (arcA, spx, and tcaR). Expression levels
of these genes were analyzed in biofilm using the wild-type strain COL, the msa mutant,
and the complemented msa mutant. A change in expression level of twofold or higher
was considered significant.
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Mutation of msa resulted in a significant increase in alsS expression in biofilm.
The alsSD operon encodes acetolactate synthase and an acetolactate decarboxylase.
Previous studies have reported that mutation of the alsSD operon in S. aureus resulted in
a biofilm defect (20, 159). The biofilm defect of the alsSD mutant was attributed to the
role of this operon in the production of acetoin from pyruvate (84, 159). Acetoin
production is necessary for acid tolerance within biofilms (11, 155). The effect of overexpression of the alsSD operon as observed in the msa S. aureus mutant on biofilm
formation is not clear. One might speculate that premature build up acetoin in the
medium could signal exhaustion of glucose and lead to detachment of cells from biofilm.
Further studies are needed to explore this possibility.
Mutation of msa resulted in a significant decrease in expression of arcA in biofilm
(Table 3.2). The arcA gene encodes arginine deiminase which is a member of the
arginine deaminase (ADI) pathway. This pathway is used to generate energy using
arginine under anaerobic conditions (36, 132). The results of several studies point to the
importance of the ADI pathway in biofilm formation and pathogenesis. Some oral
bacteria have been shown generate ammonia via the ADI pathway to maintain pH
homeostasis in biofilms (19). Other studies have shown that the ADI pathway was
induced during biofilm formation (11). Additionally, bacteria in biofilm selectively
utilize six amino acids, including arginine (163), further demonstrating the importance of
the ADI pathway in biofilm formation and pathogenesis and may explain the msa mutant
biofilm phenotype. However, when arcD was disrupted in the S. aureus strain UAMS-1,
the mutant formed effective biofilms and were as virulent as wild-type in a catheter
infection mouse model despite the fact that PIA was significantly reduced (163). These
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discrepant results may be due to differences in strains, growth conditions, or infection
model but they clearly indicated the need for more studies in the role of arginine
metabolism in biofilm development and pathogenesis.
Biofilm accumulation relies on cell-cell adhesion mediated by the polysaccharide
intercellular adhesin (PIA), which is produced by the icaADBC operon, and was shown to
play a major role in biofilm accumulation (56). Recent studies, however, have indicated
that the icaADBC operon is not essential for biofilm formation in some strains (11, 35,
44, 143). We studied the expression levels of genes encoded by this operon and found
that the msa mutation reduced the expression of icaA in the post-exponential growth
phase of planktonic cultures only. In biofilm, however, the expression of icaA in the
mutant was not significantly different from wild-type (Table 3.2). The ica-dependent
pathway is primarily regulated by the icaR repressor (29). When IcaR becomes activated
by Spx, PIA levels are reduced (47, 115). We found that there was no significant
difference in expression of icaR or spx in the msa mutant compared to the wild-type. This
is consistent with findings by Tu Quoc et al. (149) that some biofilm-defective mutants
did not show altered PIA levels. Additionally, O'Neill et al. (113) recently showed that
glucose-induced biofilm formation in MRSA strains is ica-independent. This is relevant
to our data, since the COL strain is a MRSA strain and glucose was added to the culture
media to induce biofilm in this study suggesting that msa is involved in biofilm formation
using an ica-independent mechanism as was previously described in some strains (11, 30,
122). Another important locus, sasG, which is similar to accumulation-associated protein
in S. epidermidis has been shown to play a role in cell-cell adhesion and accumulation of
biofilm (11, 30, 122), however, there was no change in expression of sasG between the
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msa mutant and wild type grown in planktonic cultures as determined by DNA
microarray experiments in our lab.
Conclusions
In summary, mutation of the msa gene in strain COL of S. aureus results in a
weak biofilm at the accumulation stage resulting in an immature biofilm. This defect is
likely mediated by the reduced expression of sarA in the msa mutant. Our results
suggested that the weak/unstable biofilm defect in the msa mutant is an intermediate
phenotype between the sarA mutant and wild-type. However, it cannot be ruled out that
the contribution of other loci that fall under the influence of msa in a sarA-independent
manner (e.g., arcA) could be responsible for this phenotype. Our findings emphasize the
complex nature of biofilms and indicated that several independent regulators and
environmental stimuli contribute to the establishment of sessile communities of S.
aureus. The intermediate phenotype of the biofilm formed by the msa mutant is a helpful
clue in deciphering the sarA-mediated mechanism of biofilm formation, which is still
unclear. Sequence analysis shows that Msa is a putative membrane protein (108, 130)
suggesting that it may play a role in environmental sensing that feeds into the sarA
regulon to contribute to biofilm formation.
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CHAPTER IV
MSA PLAYS A CRITICAL ROLE IN THE REGULATION OF ANTIBIOTIC
RESISTANCE MECHANISM OF METHICILLIN-RESISTANT STAPHYLOCOCCUS
AUREUS (MRSA)
Abstract
Antibiotic resistance in Staphylococcus aureus has become an issue of paramount
importance as the rate of MRSA (Methicillin-Resistant Staphylococcus aureus)-related
deaths have surpassed HIV-related deaths in the United States over the last decade. S.
aureus is the causative agent of life-threatening disease such as endocarditis and
osteomyelitis. Resistance to B-lactams has been associated with several mechanisms
including production of lactamases, expression of alternative penicillin-binding proteins
(PBP) and global regulators. Further analysis of resistance mechanisms in MRSA, have
now been expanded to include fem and aux-family of genes. The fem (factors essential in
methicillin-resistance) and aux (provisionally named as auxiliary genes involved in
methicillin-resistance) together comprise more than 35 genes that are involved in
methicillin resistance. While the functions of some of these gene products are still
unknown, a majority of these genes are involved in cell wall or cell-wall precursor
synthesis. The modulator of SarA (msa) gene controls the expression of various genes
either independently or via sarA. In this study, we show that mutation of the msa gene
leads to increased susceptibility (MIC 3 ȝg/ml) to methicillin and oxacillin in comparison
to wild type MRSA strain COL (MIC 1600 ȝg/ml). This effect was confirmed under
biofilm growth conditions as well.
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In order to define the role of msa in the antibiotic resistance mechanism, we
analyzed the expression of several aux, fem, mur and pbp genes that are affected by
mutation of msa using real time quantitative-PCR and DNA microarrays. Expression
analysis showed that upon challenge with oxacillin, femA, femB, femX and femD (glmM)
genes in the msa mutant were differentially expressed in comparison to wild type strain
COL. FemABX are involved in forming the pentaglycine peptidoglycan cross-bridge in
S. aureus; FemD is involved in synthesizing the precursors of UDP-MurNAcpentapeptide. Disruption of the fem genes has been shown to reduce or abolish methicillin
resistance. Along with the fem genes such as aux14, sigB, mecA, murAB and mraY were
all differentially expressed in the msa mutant in comparison to the wild type strain COL.
Additionally, functional assays were done to further characterize the role of msa in
regulating antibiotic resistance. The results from this study collectively indicated that msa
plays an important role in regulating cell wall and cell wall precursor synthesis resulting
in methicillin resistance.
Introduction
Antibiotic Resistance in Staphylococcus aureus
S. aureus is now the leading cause of nosocomial infections. Slowly, communityacquired MRSA (CA-MRSA) infections have also started to spread in the general,
otherwise healthy population and have now become a serious medical issue that requires
the collective efforts of researchers, clinicians, policy makers and the general public to
bring it under control. With increasing efforts being invested into understanding CAMRSA strains, it is becoming clearer that the genetic background of a strain is more
important in determining its virulence potential than the presence or absence of mec
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elements. It is important now more than ever to find chromosomally encoded factors that
confer MRSA strains with the ability to adapt against almost all antibiotics.
Mechanisms Involved in Resistance
Antibiotic resistance in Staphylococcus aureus has become an urgent national
medical issue as the rate of infected MRSA cases have steadily increased over the last
decade. Various therapeutic agents, starting from ȕ-lactams such as Penicillin
(introduced into clinical practice the 1940s; >95% resistance) to glycopeptides like
Vancomycin (introduced in 1956; resistance rare in the U.S.), have already seen
resistance in some region or the other around the world (69). Various factors are
involved in antibiotic resistance. In the case of MRSA strains, antibiotic resistance is
primarily mediated by the non-native mecA gene. Pbp2a, the protein product of the mecA
gene takes over as the major transpeptidase in building the peptidoglycan layer when
challenged with a ȕ-lactam such as methicillin or oxacillin. Pbp2, the native penicillinbinding protein 2, has been shown to have a low level of activity in consensus with
Pbp2a. The other penicillin-binding proteins—Pbp1, Pbp3 and Pbp4—are inactivated in
the presence of ȕ-lactams. Pbp2a and Pbp2 essentially maintain the peptidoglycan layer
and enable the cell to survive even in the presence of inhibitory levels of antibiotics (86).
Apart from the PBPs, other auxiliary factors are critical in the peptidoglycan layer
maintenance and have been studied as possible targets for therapeutic agents (83).
Consequent studies to understand antibiotic resistance mechanisms in S. aureus have led
to the discovery of several other factors that are important for the MRSA resistance
phenotype. In 1999, de Lencastre et al. (40) utilized random transposon mutagenesis and
identified the existence of fem (factors essential for methicillin resistance) genes
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necessary for ȕ-lactam resistance. Several studies have been conducted to identify the
role of specific fem genes. In 2002, Berger-Bachi and Rohrer (12) identified several
auxiliary factors involved in cell-wall precursor formation and turnover, regulation,
transport, and signal transduction. These factors, it was concluded, could play an
important role in the level of resistance exhibited by MRSA strains.
Penicillin-Binding Proteins
Methicillin-susceptible S. aureus (MSSA) strains carry three high-molecular-mass
penicillin-binding proteins and one low-molecular-mass penicillin-binding protein.
Collectively, these proteins are involved in the construction and cross-linking of the
peptidoglycan layer. Pbp1 (85 kDa), present at approximately 185 copies per cell, is an
essential PBP that is involved in cell division process (117, 120, 152). Pbp2 (81 kDa),
present at 460 copies per cell, is a bifunctional PBP that conducts both transpeptidase and
ȕ-lactam-insensitive transglycosylase activities (91, 120). Penicillin-binding protein 3
(75 kDa), present at 150 copies per cell, and the low-molecular-mass, 45 kDa Pbp4,
present at 285 copies per cell are not essential for growth (76, 120, 158). Inactivation of
Pbp3 did not cause any changes in the cell wall composition, nor did it affect the growth
rate. It was concluded that Pbp1 might be taking over the role of Pbp3, thus accounting
for the lack of phenotypic alterations (49, 118, 120). Recent studies, however, have
shown that Pbp4 is essential for ȕ-lactam resistance in community-acquired MRSA
strains. In fact, it was shown that in these strains, a functioning Pbp4 was necessary for
the full expression Pbp2 when challenged with oxacillin (103). It is possible that this
Pbp4 requirement could be specific to CA-MRSA strains.
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MRSA strains on the other hand, express an additional PBP called Pbp2a that is
encoded by the mecA gene. PBP2a has a lower affinity to ȕ-lactamase-resistant ȕ-lactams
than the native PBP2. It is believed that Staphylococcus sciuri may have been the source
of Pbp2a, which, through horizontal gene transfer between staphylococci species may
have entered into S. aureus (31). Pbp2a is a high molecular weight class B transpeptidase
that catalyzes the formation of cross-bridges in bacterial peptidoglycan. Pbp2a requires
two things when faced with the task of building the peptidoglycan layer, a) It requires a
pentaglycine-decorated muramyl-pentapeptide precursor which depends on the integrity
of intercellular cell-wall-building machinery that involves a number of auxiliary genes
(fem genes: femA, femB, femC, femX) and b) It needs the transglycosidase activity of the
PBP2 protein since PBP2a is only a transpeptidase (86). Either of the bla or mec
regulatory proteins, BlaI and MecI, respectively, can control the production of PBP2a in
staphylococci (137). ȕ-lactam binding to the extramembrane sensor of the signal
transducers, BlaR1 or MecR1, leads to the autocleavage of the cytoplasmic domains of
these molecules. This is followed by cleavage of the cognate repressor, BlaI or MecI,
respectively and to the transcription of blaZ or mecA (161). Several studies have
concluded that the amount of Pbp2a does not correlate with the level of ȕ-lactam
resistance exhibited by a strain (38). This suggested that there were chromosomal factors
in addition to the SCCmec involved in high level methicillin resistance. The fact that
methicillin resistance is inherently linked to the genetic background of a particular strain
and its response to the environment was further evidenced by the changes in level of
methicillin resistance to external conditions such as pH, osmolarity, temperature and
growth medium (18, 94, 138).

46
fem and aux Genes
Over the last decade, several genetic factors involved in high-level methicillin
resistance have been identified and characterized using transposon mutagenesis (12, 40).
de Lancastre et al., constructed a Tn551 transposon library in the highly and
homogenously resistant MRSA strain COL. Insertional mutants that showed at least a 15fold decrease in MIC levels from wild type levels (1600 ȝg/ml) were identified and
sequenced producing over 20 new chromosomal factors involved in methicillin
resistance. These genes were named factors essential for the expression of methicillin
resistance or fem genes. The femA gene encodes for a 48 kDa protein that belongs to the
FemABX family of nonribosomal peptidyl transfereases. These three transferases are
responsible for synthesizing the pentaglycine interpeptide bridge for the peptidoglycan
layer. FemA, specifically, adds the 2nd and 3rd glycine to the pentapeptide interpeptide.
An inactivated femAB, leads to the reduction of the interpeptide to a monoglycine,
leading to a poorly cross-linked peptidoglycan. In MRSA strains, methicillin-resistance
is completely abolished upon inactivation of femA. (70) The protein product of the femB
gene is responsible for adding the 4th and 5th glycine to the pentapeptide interpeptide
bridge. Henze et al. showed that a transposon mutant of the femB gene exhibited
increased levels of beta-lactam susceptibility in amounts comparable to a femA mutant
(64). femX, also known as fmhB, is an essential gene that adds the first glycine to the
pentapeptide interpeptide (148). The fact that these three gene products are critical in the
proper cross-linking of the peptidoglycan layer, makes them an attractive
antistaphylococcal target (83).
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Other Factors Involved in Resistance
Several studies have contributed to a better understanding of additional factors
involved in ȕ-lactam resistance. It is clear that the survival of S. aureus despite an
onslaught of antibiotics is a testament to its highly complex and redundant regulatory
mechanism. A comprehensive list of chromosomal genes involved in ȕ-lactam resistance
is listed in Table 4.1 below. Of importance are genes such as glmM (also known as
femD), sigB, abcA, and ccpA. GlmM is a phosphoglucosamine mutase that converts
glucosamine 6-phosphate to glucosamine 1-phosphate. This is the initial step in the
production of UDP-N-acetylglucosamine, the nucleotide sugar that is involved in
peptidoglycan synthesis. GlmM mutants exhibited a 5% decrease in peptidoglycan crosslinking, however, did not adversely affect the fitness of S. aureus. This indicates that
there may be alternative pathways to synthesize glucosamine 1-phosphate (53). SigB is a
stress-response regulator that controls the expression of various virulence factors and
global regulators (13). Wu et al. showed that upon inactivation of SigB there was a
drastic reduction in methicillin resistance (from 1600 ȝg/ml to 12 to 25 ȝg/ml). The
authors concluded that a functional stress-response system is essential in order for
methicillin resistance to occur (157).
AbcA is an ATP-dependent transporter that is involved in autolysis. Expression of
abcA is induced by methicillin and is regulated by the agr system. Overexpression of
abcA leads to enhanced methicillin resistance (133, 147). The carbon catabolite protein
(CcpA), which is responsible for regulating glucose-specific carbon source utilization in
S. aureus, was recently shown to be involved in regulation of virulence factors, biofilm
formation and resistance to methicillin (135, 136). The inactivation of ccpA reduces
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methicillin resistance (40). It is possible that the role of CcpA is a consequence of
metabolic activity rather than deliberate regulation of virulence factors.
Table 4.1
Factors Encoded by the S. aureus Genome That Affect Methicillin Resistance
Gene ID
Number1

Gene, Synonym

Gene description

SA0104

norG

GntR-like transcriptional regulator of
multidrug transporters

lytSR

Two-component sensor histidine kinase, response regulator

lrgA
lrgB

Antiholin-like proteins

yabJ-spoVG

sigB-dependent regulatory operon

sarA
pbpD
abcA
graR
graS
rat, mgrA

Stapyhylococcal accessory regulator A
Penicillin-binding protein 4
ATP-dependent transporter

SA0250,
SA0251
SA0252
SA0253
SA04550456
SA0573
SA0598
SA0599
SA0614
SA0615
SA0641

Two-component sensor transducer system

SA0702

llm, tagO

SA0793
SA0876
SA0909
SA1075
SA11491150
SA1193
SA1194
SA1195
SA1206
SA1207
SA1249
SA1283
SA1458
SA1557
SA1665
SA17011700
SAS065,
SA1842-4
SA1869

dlt operon
murE
fmtA
hmrB, acpP

Regulator of autolytic activity
Lipophilic protein,
undecaprenyl-phosphate-Į-N-acetylglucoasminyl-1phosphate transferase
D-Alanyl-lipoteichoic acid synthesis operon
UDP-N-actetyl tripeptide synthetase
UDP-N-acetylglucosamine transferase
Acylcarrier protein

glnRA

Glutamine synthetase operon

mprF, fmtC
msrA2
msrR
femA
femB
sa1249
pbpB
lytH
ccpA

Lysylphosphatidylglycerol synthetase
Methionine sulfoxide reductase
Membraen prtein with extracellular LytR-CpsA-Psr domain
Nonribosomal peptidyltransferase aminoacyltransferase
Nonribosomal peptidyltransferase aminoacyltransferase
Hypothetical protein
Bifunctional transpeptidase-transglycosylase
N-Acetyl-muramoyl amidase
Carbon catabolite control repressor
DNA-binding protein
Two-component sensor transducer system mediating the
cell wall stress stimulon

vraSR operon
agr operon

Accessory gene regulator

sigB

Alternative, stress inducible sigma factor B
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Table 4.1 (continued).
Gene ID
Number1

SA1886
SA1935
SA1959
SA1964
SA1965
SA2057
SA2062
SA2329SA2328
SAS030

Gene, Synonym

Gene description

murF
hmrA
glmS
fmtB, mrp,
sasB
glmM, femD,
femR315
fmhB, femX
sarV

UDP-N-acetylmuramyl-pentapeptide synthetase
Similar to amidase
Glucoasmine-fructose-6-phosphate aminotransferase
Cell envelope protein with LPXTG-motif, function uknown,
truncated in some MRSA strains

cidA-cidB

Holin-like protein

graF

Protein with a bipartite nuclear targeting domain

Phosphoglucoasmine mutase
Nonribosomal peptidyltransferase aminoacyltransferase
Transcriptional regulator

Note: 1Gene ID numbers correspond to those of the S. aureus N315 genome. Source: Table 8.1, “Resistance to ȕ-lactam Antibiotics,”
p. 177-178. Staphylococci in Human Diseases. Eds. Kent B. Crossley et al., 2010. Wiley-Blackwell.

Role of Msa in Antibiotic Resistance
Tortonda et al. recently reported on studies concerning the effect of cell-wall
antibiotics on sarA and mgrA in the homogenously methicillin resistant strain COL (146).
Although the sarA and mgrA single mutants showed a decrease in MIC, the sarA/mgrA
double mutant was affected the most by oxacillin. This effect was also seen in in vivo
studies using a rabbit endocarditis model. The authors of this study concluded that
resistance to oxacillin is greater when both sarA and mgrA are present, i.e., sarA plays
some role in resistance to oxacillin. Since Msa is suspected to be a putative membrane
protein and the fact that it positively regulates SarA, it is possible that Msa could be
sensing environmental signals (e.g., oxacillin) and affecting changes in gene expression
along with sarA, a global regulator, to cope with the presence of antibiotics.
Following this reasoning, an oxacillin MIC assay was done with the wild type,
homogenously resistant strain COL, its isogenic msa mutant and the complemented msa
mutant. MIC of oxacillin was determined using the microdilution broth method according
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to the guidelines provided by The Clinical and Laboratory Standards Institute (CLSI).
Additionally, the Etest Antibiotic Susceptibility Assay was performed as confirmation to
the MIC assay. Details regarding the results of these tests are discussed in the ‘results and
discussion’ section. Briefly, the mutation of the msa gene rendered the strain
hypersusceptible to oxacillin in comparison to the wild type strain COL. This
phenomenon was evident in the E-test as well. In order to understand the regulatory
mechanisms involved in msa mediated antibiotic resistance, additional genetic and
phenotypic experiments were conducted to elucidate possible pathways by which the msa
gene regulated antibiotic resistance.
Materials and Methods
Bacteria and Growth Conditions
The homogeneously Methicillin-Resistant S. aureus (MRSA) strain COL was
used in this study. Strains were grown on tryptic soy agar (TSA) or in tryptic soy broth
(TSB) at 37°C under constant aeration, supplemented with antibiotics where appropriate.
Erythromycin 10 ȝg/ml and chloramphenicol 10 ȝg/ml were used to select for the msa
mutant and complemented msa mutant, respectively. Meuller-Hinton broth (MHB) or
agar (MHA) with 2% NaCl (cation-adjusted for oxacillin) was used in determining the
Minimum Inhibitory Concentration (MIC).
Phage Farming and Transduction
Generalized transduction with phage ĭ11 was utilized to generate an msa mutant
and a complemented msa mutant in the COL strain. A phage lysate was prepared by
overlaying TSA plates with TOP Agar (3 grams of TSB, 0.7 grams of Bacto™ Agar, 100
ml dH20, autoclaved and cooled to 50°C before use) containing 100ȝl of cells from a
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moderately-thick (1/4th of a plate) suspension of the donor strain, 100ȝl of phage (10-fold
serial dilutions, from -1 to -5) and 40ȝl of 500mM CaCl2. The plates were incubated
overnight at room temperature. The next day, the plate with the least amount of phage
and the most clearing was harvested and the suspension was filter-sterilized using a
0.2ȝm filter. A 100ȝl aliquot was plated on a TSA plate to test for sterility of the lysate.
To perform the transduction, 500 ȝl of recipient-strain cells (from a very heavy
suspension; full plate of cells into 2ml of medium) were added to 500 ȝl of the prepared
phage lysate in 1ml of TSB containing 20 ȝl of 500 mM CaCl2. The mixture was
incubated at 37°C with vigorous shaking for exactly 20 minutes. At the end of 20
minutes, 1ml of ice-cold 0.02M sodium citrate was added and the tube was placed on ice.
Cell pellets were collected by centrifugation and the pellets were resuspended in 500 ȝl
of 0.02M sodium citrate before being plated onto TSA plates containing selective
medium and 500 ȝg/ml of sodium citrate. Colonies appearing on these plates were restreaked and screened using PCR and/or restriction digestion.
Minimum Biofilm Eradication Concentration (MBEC) assay
The MBECTM Physiology and Genetics Assay (Innovotech, Inc., Canada) was
used to determine the effect of oxacillin on msa mutant biofilm versus the wild type
biofilm. Procedures were carried out as per instructions of the manufacturer. Briefly, the
MBEC device uses a standard 96-well configuration with two parts: 96 identical
polystyrene pegs protruding from a lid and a 96-well microtitre plate base. Pegs were
immersed in growth medium containing the test strains (matching 1.0 McFarland
standard) and were incubated overnight at 37°C. Biofilm formed on these pegs were
rinsed with PBS and transferred to another 96-well plate containing varying
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concentrations of antibiotics. After overnight incubation, the cells in the biofilm were
disrupted and collected into fresh growth medium using a water bath sonicator. Collected
cells were allowed to grow for another 24 hrs before assessing the MBEC (the lowest
concentration of antibiotics that was able to eradicate cells in a biofilm).
Culture Conditions for Oxacillin-Induced Analysis
Tryptic Soy Broth (TSB) was inoculated with the respective overnight cultures.
Cells were grown until OD560nm of 0.9 with shaking at 150rpm and at 37°C. At this point,
cells were split into two flasks. One volume was treated with oxacillin (5X lower than
MIC) and the other was left untreated (control). Both cultures were incubated again with
shaking at 150rpm and at 37°C. Samples were collected from control and oxacillintreated cultures at 1 hour and 6 hours post addition of oxacillin. These samples were
processed additionally for TEM and Real-time quantitative PCR analysis.
Transmission Electron Microscopy
Cell pellets were collected as mentioned above and resuspended in a 4%
gultaraldehyde solution. Then the cells were treated with osmium tetroxide, dehydrated
through a graded series of alcohols and propylene oxide, and then infiltrated with Epon
plastic. The Epon blocks were cured overnight in a 60°C oven and 70 nm sections were
cut using a Leica ultramicrotome. Sections were stained with uranyl acetate and lead
citrate and viewed on a Leo 912 transmission electron microscope.
Atomic Force Microscopy
AFM was done as previously described by Dubrovin et al., (42). Briefly, cell
pellets were collected as mentioned above and were washed 3x in ice-cold sterile distilled
water for 10 minutes at 10,000 rpm and 4ΣC. Then the cells were resuspended in 1/10th
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the volume using ice-cold sterile distilled water. Immediately, 5μl of resuspended cells
were deposited on freshly cleaved mica as a substrate. The sample was allowed to air dry
for 5-10 minutes for adsorption and then rinsed with sterile distilled water three times and
dried in nitrogen flow.
All AFM measurements were recorded in air using a Nanoscope III microscope
(Digital Instruments, Santa Barbara, CA) equipped with 150 μm scanner in tapping
mode. The commercial noncontact silicon cantilevers had typical stiffness of 20-80 N/m;
their resonance frequency was in the range of 321-373 kHz. The scan frequency was
about 0.25 Hz. All AFM images were recorded simultaneously in two channels: height
and phase. Image processing was performed using Gwyddion software (version 2.20,
http://gwyddion.net/). For accurate numerical measurements, height images were used.
RNA Isolation and cDNA Synthesis
Total RNA was isolated from cell pellets (collected as mentioned above) using the
RNeasy Mini column (Qiagen). RNA was treated twice with DNase and analyzed for
quality and concentration using Agilent’s Total RNA Nano 6000 protocol. Appropriate
amounts of total RNA were converted to cDNA using BioRad’s iScript cDNA synthesis
kit. cDNA was stored at -20°C until use. Differential gene expression data was derived
from at least two independent biological replicate samples.
Real-time Quantitative PCR (RT-qPCR)
Gene expression analysis by RT-qPCR was performed with all reactions done in
triplicate using the iQ SYBR Green Supermix and the BioRad iCycler iQ Real-time PCR
detection system. The constitutively expressed gyrase gene (gyr) was used as an
endogenous control. Primer specificity and efficiency was measured as described
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previously (130). Expression analysis for each gene was based on at least two
independent experiments. Two-fold or higher changes in expression were considered
significant.
Western-blot Analysis
Cells were collected as described above and were frozen at -80ΣC. Cell pellets
were resuspended in 300 μl of sterile 1x PBS. A sonicator was used to disrupt the cell
membrane and lyse the cells. Cells were sonicated (Misonix XL 2000, Newton, CT; set at
14 volts) for 15 seconds at a time to avoid overheating and kept in ice for cooling. After
10 cycles, 10 μl of the cell mixture was added to 20 μl of 3x sample buffere and boiled
for 5 mins at 95ΣC. Protein concentration was measured using Bradford assay. The total
protein mixture from each of the strains were separated by sodium dodecyl sulfatepolyacrylamide gel electrophoresis and transferred onto a PVDF membrane for western
blot analysis as described previously by Zhang et al. (161). The primary polyclonal
antibody, anti-pbp2a, was custom ordered from ProSci, Inc., (Poway, CA) and was used
as per supplier’s instructions. Blotting and analysis was done as previously described by
Blevins et al. (15).
Triton X-100 Induced Autolysis
Autolysis assay was conducted using Triton X-100 as described by Manna et al.
(97). Overnight bacterial cultures were diluted to an OD650 of 0.5 in TSB-N (TSB + 1M
NaCl). Cells were grown until OD650 reached 0.7-1.2. Cells were washed twice with icecold dH2O and harvested by centrifugation at 10,000 RPM for 5 min. Washed cells were
resuspended in 0.05M Tris-HCl, pH 7.5 buffer (control) or 0.05M Tris-HCl, pH 7.5
buffer containing 0.05% (wt/vol) Triton X-100 (stimulated). Triton X-100 stimulated
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lysis was recorded by incubating cells at 30°C with shaking and measuring optical
density at OD650 every 30 min.
Heat Shock Assay
Fresh medium was inoculated with overnight cultures of respective strains. The
cells were allowed to grow until they reached exponential growth (OD560 0.7). Cells were
split into two and were allowed to grow in 42ΣC and 37ΣC as test and control samples,
respectively. The growth rate was monitored every hour. Results from the 42ΣC
incubation are reported.
Microarray Analysis
Microarray experiments were done using S. aureus COL genome microarrays
(version 6.0), provided by Pathogen Functional Genomics Resource Center (PFGRC).
The entire experiment was done according to the TIGR protocols found on their website
at: http://pfgrc.tigr.org/protocols/protocols.shtml
RNA Labeling and Hybridization
RNA labeling and hybridization was done according to the TIGR protocol
(Standard operating procedure no. M0007:http://pfgrc.tigr.org/protocols/protocols.shtml).
Briefly, random hexamers (Invitrogen) as primers were annealed to 2.5 μg of the total
RNA (70oC for 10 min, followed by snap-freezing in ice for 1 min), along with
RNaseOUT recombinant ribonuclease inhibitor (Invitrogen). The primers were then
extended using SuperScript II reverse transcriptase (Invitrogen) with 0.1 M DTT and 12.5
M of aa-dNTP/aa-dUTP mix (Ambion, Austin, TX) at 42oC overnight. Residual RNA
was removed by alkaline treatment with 1 M NaOH followed by neutralization with 1 M
Tris (pH 7.4). The resulting cDNA was purified using Qiagen MinElute PCR purification
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kit (Qiagen) and labeled with Cy3 and Cy5 mono-Reactive dyes (Amersham Biosciences,
Pittsburg, PA) as per manufacturer’s instruction.
Labeled cDNA was purified using MinElute PCR purification kit and hybridized
with S. aureus COL genome microarrays (version 6.0), provided by Pathogen Functional
Genomics Resource Center (PFGRC), as per the TIGR protocol (Standard operating
procedure no. M0008: http://pfgrc.tigr.org/protocols/protocols.shtml). Briefly, the slides
were treated with a preheated pre-hybridization buffer (5X SSC [Ambion], 0.1% SDS
and 1% BSA [Sigma, St. Louis, MO]) at 42oC for 1 hr. Slides were then washed with
distilled water followed by washing with isopropanol and dried by centrifuging. The
dried Cy3 and Cy5 labeled cDNA was resuspended using hybridization buffer (50%
formamide, 5X SSC, 0.1% SDS and 300 μg sheared salmon sperm DNA [Ambion]) and
denatured at 95oC. The sample was then applied to the pre-hybridized slides under the
LifterSlip (Fisher, Pittsburg, PA). The slides were incubated at 42oC overnight. Next day,
the hybridized slides were serially washed with low, medium and high stringency wash
buffers, dried by centrifuging and scanned using Axon 4200A scanner (Molecular
Devices, Sunnyvale, CA). Microarray scans were saved as TIFF images.
Microarray Data Analysis
GenePix Pro 6 (Molecular Devices) was used to extract the spot intensity values
and generate GPR files from the microarray image files. Further data analysis was done
using the Acuity 4.0 software (Molecular Devices). Four hybridizations were performed
for this experiment, including a biological replicate and a dye-swap experiment for each
replicate to account for dye-bias. Spots flagged as empty or bad were excluded and the
raw data from each slide was normalized using LOWESS method, with background
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correction. The data from the replicates were combined (using the median value) and a
one sample t-test was performed. The volcano plot was used with a fold change cut-off of
>= 3 and a p-value of <0.05 to filter the genes that are differentially expressed.
ORF IDs in the list of differentially expressed genes were mapped to S. aureus
N315 IDs using TIGR-PFGRC annotation file: http://pfgrc.tigr.org/annotationPages.shtm
Results and Discussion
msa is Involved in Antibiotic Resistance
Since methicillin is no longer used in the clinical settings, oxacillin was used in
this study. MIC values of the msa mutant showed that the disruption in the msa gene
rendered the homogenously methicillin-resistant strain COL hypersusceptible to
oxacillin. Minimum inhibitory concentration of oxacillin on average went from 1000
μg/mL down to ~4 μg/mL (Table 4.2). The complemented msa mutant was able to
restore resistance back to wild type levels. Etest results also confirmed the drastic
differences in MIC values (Figure 4.1). Wild type strain COL’s oxacillin MIC was very
high at >256 ȝg/ml. The Etest strip had an upper limit of 256 ȝg/ml, therefore it does not
reflect the higher wild type MIC values seen with the micro-broth dilution method.
Although a lawn-like growth did not occur in the wild type Etest, according to
manufacturer’s instructions, the presence of colonies is indicative of resistance (Figure
4.1). The msa mutant, on the other hand, had a clear zone of inhibition starting at 1.5
μg/mL, providing further evidence that the msa mutant is hypersusceptible to oxacillin.
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Table 4.2
Oxacillin MIC Values of COL, msa, and Complemented msa Mutant
Strains

MIC
(μg/mL)

COL

1000

msa-

3.906

msa complement

1000

RN6390

0.9765

Note. The msa mutant was hypersusceptible to oxacillin in comparison to the wild type strain COL and the complemented msa mutant.
The methicillin-susceptible S. aureus (MSSA) strain RN6390 was used as a control. The assay was performed three independent times
and an average value is reported here.

COL

msa-

Figure 4.1. Oxacillin E-test using the COL wild type and msa mutant strains.
Msa is necessary for growth in the presence of high levels of antibiotics.
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Antibiotic Susceptibility Prevails under Biofilm Conditions
Since antibiotic resistance is amplified in a biofilm state of growth (67), a
minimum biofilm eradication concentration (MBEC) assay was performed to assess and
compare the oxacillin concentration required to inhibit growth of cells within a biofilm in
the msa mutant versus the wild type strain COL. Remarkably, the msa mutant was again
hypersusceptible to oxacillin, albeit at a relatively higher concentration in comparison to
planktonic growth conditions (Table 4.3). This effect is probably due to the protective
environment afforded by the biofilm. In the msa mutant, however, the biofilm is defective
(see Chapter III) and does not mature into a robust, protective environment. So, any
protection afforded by the biofilm is at best very minimal.
Table 4.3
msa Mutant Biofilm is Susceptible to Antibiotics as Evidenced by the Minimal Biofilm
Eradication Concentration (MBEC) Assay
Strain
COL, wild type
msa mutant
msa complement

MBEC (μg/ml)
1500
187.5
1500

Note. Biofilm is grown on uniform individual pegs and then is exposed to varying concentrations of antibiotics. Cells that are able to
resist the antibiotics are allowed to recover in fresh medium and the lowest concentration of antibiotics that was able to eradicate cells
in a biofilm is reported as the MBEC. Results are an average of two independent runs.

Msa Aids in Maintaining Cell Integrity in the Presence of Antibiotics
Several studies have shown that the morphology of the cell wall of strains with
increased susceptibility to ȕ-lactams often show some degree of damage as a result of
exposure to these antibiotics. In order to visualize the damaged caused as a result of a
non-functional msa gene, transmission electron microscopy (TEM) and atomic force
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microscopy (AFM) studies were conducted. TEM and AFM were chosen to discern
differences in cell wall stability and cell surface organization, respectively. Cells were
treated and harvested as in other procedures, before being prepared for each of these
microscopy procedures. TEM images (Figure 4.2) of the msa mutant at 4000x
magnification showed that there was increased lysis of the msa mutant cells upon
addition of oxacillin. It is interesting to note the degree of damage incurred by the cells
when the amount of oxacillin added to the msa mutant was just 0.625 μg/ml, whereas the
amount added to the wild type strain and the complemented strain was 320 μg/ml (1/5th
of their respective MICs). Upon closer investigation (Figure 4.3) at a higher
magnification of 20000x, the effects of msa mutation on the cell wall integrity were even
more evident. Majority of the wild type and complemented msa mutant cells were intact
in comparison to the msa mutant. It is possible that this loss in cell wall integrity could be
due to the lack of msa—a putative membrane protein, which may be involved in sensing
the external environment and relaying the appropriate signals to prepare the cell wall
machinery for an onslaught of antibiotics. Genetic and functional studies were conducted
to further understand the role of msa in this process (see below). The complemented msa
mutant on average exhibited two different cell sizes when exposed to oxacillin. This
could be possibly be a result of overexpression of msa in some cells versus the others,
however, further experimentation using a controlled msa expression mechanism will be
required to answer this variability exhibited by the complemented msa mutant strain.
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Figure 4.2. TEM images of wild type strain COL, msa mutant, and complemented msa
mutant at 4000x magnification. Cells in the bottom panel were treated with oxacillin at
1/5th the amount of respective MIC values and the cells in the upper panel served as
untreated controls. The msa mutant shows increased lysis upon addition of oxacillin.
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Figure 4.3. TEM images of wild type strain COL, msa mutant, and complemented msa
mutant at 20,000x magnification. Cells in the bottom panel were treated with oxacillin at
1/5th the amount of respective MIC values and the cells in the upper panel served as
untreated controls. The msa mutant showed increased lysis upon addition of oxacillin,
whereas majority of the wild type and complemented msa mutant cells were able to
maintain cell wall integrity.

AFM images were obtained as previously described by Dubrovin et al. (42).
Measurements were recorded in air using a Nanoscope III microscope (Digital
Instruments, Santa Barbara, CA) equipped with 150 μm scanner in tapping mode. The
commercial noncontact silicon cantilevers had typical stiffness of 20-80 N/m; their
resonance frequency was in the range of 321-373 kHz. The scan frequency was about
0.25 Hz. All AFM images were recorded simultaneously in two channels: height and
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phase. Image processing was performed using Gwyddion software (version 2.20,
http://gwyddion.net/). For accurate numerical measurements, height images were used.
Preliminary AFM images of the msa mutant’s cell surface (Figure 4.4.) showed that the
cell wall could possibly be damaged as a result of msa mutation (possible regions of
perturbations in the cell wall are indicated with blue arrows). In comparison, the wild
type strain COL (Figure 4.5.) did not show any distinct damages in the cell wall surface.
In order to conclusively demonstrate that mutation of msa causes phenotypic changes in
the cell wall of S. aureus, additional AFM imaging using control cells under normal and
oxacillin-induced conditions will be required.

Figure 4.4. AFM images of the msa mutant cells exposed to oxacillin. Blue arrows
indicate possible locations of cell wall misformation due to mutation of msa.
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Figure 4.5. AFM images of the wild type COL cells exposed to oxacillin.
Msa Regulates mecA Expression
MRSA strains express an additional penicillin-binding protein (Pbp) called Pbp2a
that is encoded by the mecA gene carried on the SCCmec mobile element. Real-time
quantitative PCR was performed to compare mecA gene expression in oxacillin-induced
and control samples of wild type strain COL, the msa mutant and the complemented msa
mutant. Along with the mecA gene, the SCCmec element usually carries the mecA
regulatory genes such as mecI and mecR1. In the MRSA strain COL, however, the mecI
gene is non-functional. Therefore, expression of the mecR1 gene was analyzed. Relative
gene expression was calculated using the delta-delta Ct method (Table 4.4). In
comparison to the control samples, oxacillin-induced samples from the msa mutant
showed a drastic reduction (undetectable levels) in mecA gene expression.
Complemented msa mutant restored mecA gene expression to near wild type levels. Next,
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expression levels of the Pbp2a protein were analyzed using western blot analysis. In the
msa mutant Pbp2a levels were lower than the wild type strain COL and complemented
msa mutant levels (Figure 4.6). These results were in agreement with the RT-qPCR
results, albeit not to a similar extent. Unless protein-protein interaction studies are done,
it is not possible to know whether Msa directly or indirectly (through another protein)
interacts with the Pbp2a.
Table 4.4
Relative Gene Expression of mecA and mecR1
Gene
mecA
mecR1

Planktonic Cells
0.3
1.5
4.0
<0.0001 <0.0001 <0.0001
<0.0001 <0.0001 <0.0001

Note. Relative gene expression of the mecA and mecR1 gene in the msa mutant compared to the COL wild type strain. Similar
differences were also seen in samples not treated with oxacillin. The values presented are an average of two independent runs.

Figure 4.6. Western blot analysis showing the levels of Pbp2a in the wild type strain
COL, msa mutant and the complemented msa mutant.

Msa Regulates Expression of Cell Wall and Cell Wall Precursors
Collectively, these results indicated that the msa gene plays a major role in ɴlactam antibiotic resistance in Staphylococcus aureus. Based on these results, further
experiments were necessary to narrow down the role of msa in the antibiotic resistance
mechanisms. To that effect, first, a list of several chromosomally encoded genetic factors
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involved in antibiotic resistance was generated from previous studies conducted by other
investigators (see Table 4.1). In order to achieve a manageable number of genes for initial
RT-qPCR analysis the list was further reduced to genes that showed a 3-fold or higher
difference in a microarray analysis of the msa mutant versus the wild type COL. This
microarray analysis, however, was done using samples that were collected without any
oxacillin treatment, thus it served more as a guideline rather than a definitive cut off
measure. Cells were collected from oxacillin treated and untreated control samples. Total
RNA was isolated and was used to generate the cDNA that was used as the template for
the RT-qPCR analysis. Relative gene expression of target genes was calculated using the
delta-delta Ct method and the results are summarized in Table 4.5 (untreated control
samples) and Table 4.6 (oxacillin-induced samples).
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Table 4.5
Relative Gene Expression of msa Mutant Compared to Wild Type COL in Untreated
Control Samples

Gene
femA
femB
femC
femD,
femR315,
glmM
femX,
fmhB
fmtB, mrp,
sasB
fmtC,
mprF

Gene Description

msa mutant
vs. wild
type COL2

Nonribosomal peptidyltransferase aminoacyltransferase
Nonribosomal peptidyltransferase aminoacyltransferase

-7.143*
-2.632*

Glutamine Synthetase

-1.124

SA1965

Phosphoglucoasmine mutase

-1.481

SA2057

Nonribosomal peptidyltransferase aminoacyltransferase

-1.055

SA1964

Cell envelope protein with LPXTG-motif, function
uknown, truncated in some MRSA strains

-1.942

SA1193

Lysylphosphatidylglycerol synthetase

-1.724

N315
locus1
SA1206
SA1207
SACOL
1329

llm, tagO

SA0702

hmrA
sigB
aux4
aux7
aux9
aux10
aux14
aux19

SA1935
SA1869
SA1557
SA1572
SA1137
SA1489
SA0722

murC
murD

SACOL
2092
SACOL
2116
SA1561
SA1026

murG

SA1251

mraY
pbpA
pbpB
pbpC
pbpD

SA1025
SA1024
SA1283
SA1381
SA0598

murAA
murAB

Lipophilic protein,
undecaprenyl-phosphate-Į-N-acetylglucoasminyl-1phosphate transferase
Similar to amidase
Alternative, stress inducible sigma factor B
Catabolite Control
Amino acid metabolism
Involved in DNA repair
Hypothetical Protein
Unknown Protein
Hypothetical Protein; Similar to ABC transporter

-2.062*
-1.220
-1.675
1.480
1.505
-1.005
-1.026
-9.091*
1.545

UDP-N-acetylglucosamine 1-carboxyvinyltransferase 1

-1.754

UDP-N-acetylglucosamine 1-carboxyvinyltransferase 2

-1.242

UDP-N-acetylmuramate--alanine ligase
UDP-N-acetylmuramoylalanine--D-glutamate ligase
UDP-N-acetylglucosamine--N-acetylmuramyl(pentapeptide) pyrophosphoryl-undecaprenol Nacetylglucosamine transferase
Phospho-N-acetylmuramoyl-pentapeptide-transferase
Penicillin-binding protein 1
Penicillin-binding protein 2
Penicillin-binding protein 3
Penicillin-binding protein 4

1.445
-1.770
-1.980
-2.381*
-1.515
-1.198
-1.923
1.870

Note: 1Where available the N315 locus ID has been listed. 2Genes with two-fold or higher gene expression have been indicated with
an asterisk.
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Table 4.6
Relative Gene Expression of msa Mutant Compared to Wild Type COL in OxacillinTreated Samples

Gene
femA
femB
femC
femD,
femR315,
glmM
femX,
fmhB
fmtB, mrp,
sasB
fmtC,
mprF

Gene Description

msa mutant
vs. wild
type COL2

Nonribosomal peptidyltransferase aminoacyltransferase
Nonribosomal peptidyltransferase aminoacyltransferase

-1.626
1.195

Glutamine Synthetase

-1.205

SA1965

Phosphoglucoasmine mutase

-3.846*

SA2057

Nonribosomal peptidyltransferase aminoacyltransferase

-2.326*

SA1964

Cell envelope protein with LPXTG-motif, function
uknown, truncated in some MRSA strains

-1.538

SA1193

Lysylphosphatidylglycerol synthetase

1.215

N315
locus1
SA1206
SA1207
SACOL
1329

llm, tagO

SA0702

hmrA
sigB
aux4
aux7
aux9
aux10
aux14
aux19

SA1935
SA1869
SA1557
SA1572
SA1137
SA1489
SA0722

murC
murD

SACOL
2092
SACOL
2116
SA1561
SA1026

murG

SA1251

mraY
pbpA
pbpB
pbpC
pbpD

SA1025
SA1024
SA1283
SA1381
SA0598

murAA
murAB

Lipophilic protein, undecaprenyl-phosphate-Į-Nacetylglucoasminyl -1-phosphate transferase
Similar to amidase
Alternative, stress inducible sigma factor B
Catabolite Control
Amino acid metabolism
Involved in DNA repair
Hypothetical Protein
Unknown Protein
Hypothetical Protein; Similar to ABC transporter

-1.460
1.320
-2.899*
1.290
2.955*
1.809
1.400
-5.714*
-1.504

UDP-N-acetylglucosamine 1-carboxyvinyltransferase 1

1.050

UDP-N-acetylglucosamine 1-carboxyvinyltransferase 2

-22.222*

UDP-N-acetylmuramate--alanine ligase
UDP-N-acetylmuramoylalanine--D-glutamate ligase
UDP-N-acetylglucosamine--N-acetylmuramyl(pentapeptide) pyrophosphoryl-undecaprenol Nacetylglucosamine transferase
Phospho-N-acetylmuramoyl-pentapeptide-transferase
Penicillin-binding protein 1
Penicillin-binding protein 2
Penicillin-binding protein 3
Penicillin-binding protein 4

1.690
-1.399
-1.449
-1.053
1.449
-1.342
1.465
2.430*

Note: 1Where applicable the N315 locus ID has been listed. 2Genes with two-fold or higher gene expression have been indicated with
an asterisk.
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Most notably among the aux genes, the expression of aux14 was down by 5.7and 9-fold in the msa mutant under oxacillin-treated and untreated conditions,
respectively (Figures 4.5. and 4.6). In a 1994 paper by de Lencastre and Tomasz (39), an
aux14 mutant (designated as strain RUSA262) was described as exhibiting distinct
abnormalities in the peptidoglycan. The MIC of methicillin for the aux14 mutant was
reported as 12 ȝg/ml in comparison to the 1600 ȝg/ml of the wild type strain COL. This
effect is similar to the hypersusceptibility seen in the COL msa mutant. The authors of
this study did not provide additional mechanistic details regarding aux14 susceptibility.
Till date, there have been no follow-up studies on aux14. Given the possibility that the
msa gene encodes for a membrane protein, it is speculated that the msa gene might be
involved in directly regulating the expression of aux14 in order to maintain cell wall
integrity. According to analysis done using SAMMD (107), microarray analysis of the
sigB regulon (13), revealed that aux14 is upregulated by the sigB gene. The sigB gene, a
stress response regulator, was expressed in the msa mutant at wild type levels in the
absence of oxacillin (Figure 4.7) However, in the presence of oxacillin the sigB
expression was down by 3-fold in the msa mutant in comparison to the wild type strain
(Figure 4.8). Therefore, the reduced expression of aux14 could be partially attributed to
the levels of sigB in the msa mutant.
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Figure 4.7. Relative gene expression analysis of the aux genes in the msa mutant vs. wild type strain COL.
Fold change values are an average of two independent runs. Two-fold decrease in fold change is indicated
with a red dashed line and a two-fold increase in fold change is indicated with a green dashed line where
applicable.
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Figure 4.8. Relative gene expression analysis of the aux genes in the msa mutant vs. wild type strain COL.
Fold change values are an average of two independent runs. Two-fold decrease in fold change is indicated
with a red dashed line and a two-fold increase in fold change is indicated with a green dashed line where
applicable.
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In order to understand if hypersusceptibility of the msa mutant to oxacillin was
due to reduced expression of the sigB gene, i.e., an inability to cope with the stress
presented by the antibiotic, a heat shock assay was performed because it is known to
induce sigB activity. Cells were grown to the exponential phase (OD560 0.7) at 37ΣC and
then transferred to 45ΣC. Differences in growth between the wild type, msa mutant and
complemented msa mutant were monitored over a 6-hour period (Figure 4.9). The msa
mutant in comparison to the wild type and complemented msa mutant did not show any
significant changes in growth. It appears that a decrease in SigB is not related to the
antibiotic susceptibility seen with the msa mutant since the mutant is able to grow similar
to wild type levels. Additional studies have to be conducted to establish a more concrete
relationship between these genes since SigB is involved in other stress-related response
mechanisms.

Figure 4.9. Heat shock assay performed on wild type COL, msa mutant and
complemented msa mutant.
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The fem genes (factors essential for the expression of methicillin resistance) are
important components of the cell wall machinery. Mutation of msa caused a 7.1- and 2.6fold decrease in femA and femB expression, respectively (Figure 4.11). The femA gene
encodes for a 48 kDa protein that belongs to the FemABX family of nonribosomal
peptidyl transfereases. These three transferases are responsible for synthesizing the
pentaglycine interpeptide bridge for the peptidoglycan layer. FemA, specifically, adds the
2nd and 3rd glycine to the pentapeptide interpeptide. An inactivated femAB, leads to the
reduction of the interpeptide to a monoglycine, leading to a poorly cross-linked
peptidoglycan. In MRSA strains, methicillin-resistance is completely abolished upon
inactivation of femA (70). The protein product of the femB gene is responsible for adding
the 4th and 5th glycine to the pentapeptide interpeptide bridge. Henze et al., showed that a
transposon mutant of the femB gene exhibited increased levels of beta-lactam
susceptibility in amounts comparable to a femA mutant (64).
femX, also known as fmhB, is an essential gene that adds the first glycine to the
pentapeptide interpeptide (148). Mutation of femX produces a null mutant. It is possible
that the drastically reduced MIC values seen in the msa mutant is due to the ill-formed
peptidoglycan layer. Interestingly, the femX, and not femA and femB, was expressed
lower in the msa mutant exposed to oxacillin (Figure 4.12). These three gene products are
critical in the proper cross-linking of the peptidoglycan layer and have been considered as
attractive antistaphylococcal targets (83). Lysostaphin is a metalloendopeptidase
produced by Staphylococcus simulans that specifically cleaves the pentaglycline crossbridges that are formed by femX, femA and femB. A lysostaphin susceptibility assay was
performed to see the effect of reduced expression of femXAB. As expected, the msa
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mutant had a slower rate of lysis in comparison to the wild type and complemented msa
mutatnt strain (Figure 4.10). It is possible that the lack of substrate for lysostaphin to act
upon was in fact the reason for reduced lysis. Indeed, Maidhof et al. have shown that the
femA mutant has reduced lysostaphin-induced lytic activity due to the lack of glycines in
the peptidoglycan (95). It is unclear at this stage why the complemented msa mutant
showed similar lysostaphin susceptibility profile as the msa mutant. Given the effect Msa
has on all three transferases, a therapeutic agent designed against Msa could serve to
disrupt the functions of all three transferases and thereby rendering the peptidoglycan
layer unstable.

Figure 4.10. Lysostaphin susceptibility assay. The msa mutant is less susceptible to
lysostaphin in comparison to the wild type strain COL. Lysostaphin’s target, the
pentaglycine cross-bridge is possibly less in the msa mutant thereby denying lysostaphin
a substrate to act upon. The results are an average of two independent runs containing
two technical replicates each.
femD, also known as glmM encodes for a phosphoglucosamine mutase that
converts glucosamine 6-phosphate to glucosamine 1-phosphate. This is the initial step in
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the production of UDP-N-acetylglucosamine, the nucleotide sugar that is involved in
peptidoglycan synthesis. GlmM mutants exhibited a 5% decrease in peptidoglycan crosslinking, however, did not adversely affect the fitness of S. aureus. This indicates that
there may be alternative pathways to synthesize glucosamine 1-phosphate (53).
Reduction in the amount of GlmM alone may not have been sufficient for the increased
susceptibility seen in the msa mutant but the combinatorial effect of reduction in the fem
and glmM genes may explain the high degree of degradation seen in the msa mutant
cells’ TEM images. Disrupting Msa’s function not only affects factors involved in
building the peptidoglycan layer, but also the factors that are involved in assembling and
processing the precursor structures involved in the peptidoglycan formation.
mur genes (murA, murB, murC, murD, murE, murF, and murG) comprise of
ligases, reductases, and transferases that are involved in assembling the building blocks
of the peptidoglycan on the cytoplasmic side of the process (43, 116) (Figure 4.13).
Although the mechanistic details of the mur genes’ regulation is yet to be fully
deciphered, a lot has been studied and understood about their sequential assembly. When
the process begins, MurA is responsible for the transfer of an enolpyruvate residue from
phosphoenolpyruvate (PEP) to the 3rd position of UDP N-acetylglucosamine.
Consequently, the enolpyruvate moiety is reduced to D-lactate, yielding UDPNacetylmuramate. Next, the stem pentapeptide side-chain (L-alanine, D-glutamine, Llysine, D-alanine, D-alanine) is added on to the recently reduced D-lactyl group in a
sequential manner by MurC, MurD, MurE and MurF. All these processes are ATPdependent. The resulting product is the UDP-N-acetylmuramyl pentapeptide (43).
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Figure 4.11. Relative gene expression analysis of the fem genes in the msa mutant vs. wild type strain COL.
Fold change values are an average of two independent runs. Two-fold decrease in fold change is indicated
with a red dashed line and a two-fold increase in fold change is indicated with a green dashed line where
applicable.
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Figure 4.12. Relative gene expression analysis of the fem genes in the msa mutant vs. wild type strain COL.
Fold change values are an average of two independent runs. Two-fold decrease in fold change is indicated
with a red dashed line and a two-fold increase in fold change is indicated with a green dashed line where
applicable.
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Figure 4.13. Protein structure of MurA, B, C, D, E and F using the oval ribbon model.
Image source: (43)
In a subset of Gram-positive organisms, murA contains a paralogue (79). In this
case, the two genes are referred to as murAA and murAB. Protein sequence analysis using
MATCHER (Waterman-Eggert local alignment tool) of MRSA strain COL revealed that
there is a 47% identity and 63.7% similarity between the two murA paralogues. In the
msa mutant, the expression of murAA remained unchanged in comparison to the wild
type (Figures 4.12 and 4.13). The expression of murAB, however, was more than 22-fold
lower in the msa mutant in samples treated with oxacillin (Figure 4.15). In contrast,
murAB levels remained similar to wild type levels in untreated samples (Figure 4.14).
Kock et al. (2004) have shown in B. subtilis that murAB cannot compensate for loss of
murAA function. Inversely, it is possible that, although transcripts of murAA are being
produced in the msa mutant in the conditions tested, it may not be fully sufficient to take
over the role of murAB. It is speculated that msa regulates the expression of murAB,
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which, under certain conditions could be partially responsible for the first step in
cytoplasmic-side of peptidoglycan biosynthesis. Further studies have to be conducted in
order to fully elucidate the significance of the loss of murAB transcript.
Murein hydrolases play important roles in a variety of cellular processes, such as
cell wall growth, cell wall turnover, cell separation, the recycling of muropeptides, lysis
induced by cell wall synthesis inhibitors, the establishment of competence for genetic
transformation, flagellum formation, sporulation, and in bacterial pathogenicity processes
(50, 68, 138). Those murein hydrolases that lead to the destruction of the cell wall and
subsequent cell lysis are called autolysins. Because of the capacity to destroy the cell
wall, the expression and activity of murein hydrolases must be tightly controlled. If
uncontrolled, these hydrolases can compromise cell wall integrity, lead to the destruction
of the cell wall, and cell lysis ensues. This reaction is similar to what happens to a typical
methicillin-susceptible S. aureus in the presence of a ȕ-lactam (144). Gustafson and
Wilkinson showed that a homogenously resistant strain such as COL has a lower
autolytic activity than susceptible strains (58). It is not inconceivable that the cell
downregulates autolytic activity while trying to maintain a proper cell wall that is being
disrupted by the antibiotics. If mutation of msa affects cell wall or cell-wall precursor
proteins, it is possible that the autolytic pathway involved in cell wall turnover and
recycling of muropeptides is affected as well. Triton X-100 induced autolytic assay (97)
was performed to compare lytic activity between the wildtype and the msa mutant. The
msa mutant in the presence of Triton X-100 had increased lysis in comparison to the wild
type strain COL (Figure 4.16). Previously it was shown that the major autolysin, atl, is
expressed nearly 3-fold lower in the msa mutant (129). It is possible that this effect of
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Figure 4.14. Relative gene expression analysis of the mur genes in the msa mutant vs. wild type strain COL.
Fold change values are an average of two independent runs. Two-fold decrease in fold change is indicated
with a red dashed line and a two-fold increase in fold change is indicated with a green dashed line where
applicable.
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Figure 4.15. Relative gene expression analysis of the mur genes in the msa mutant vs. wild type strain COL.
Fold change values are an average of two independent runs. Two-fold decrease in fold change is indicated
with a red dashed line and a two-fold increase in fold change is indicated with a green dashed line where
applicable.
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increased lysis in the mutant is a result of another unknown autolytic mechanism that was
repressed by the msa gene. However, studies have shown that gene expression is different
under biofilm and planktonic growth conditions (11). Thus, it is also possible that atl is
differentially regulated under the conditions used in this study and is possibly the reason
for the increased autolytic activity seen in the msa mutant.
The mraY gene encodes for a Phospho-N-acetylmuramoyl-pentapeptidetransferase that is responsible for completing the first membrane step of peptidoglycan
biosynthesis (17). MraY is an essential integral membrane protein that transfers the
Phospho-N-acetylmuramoyl-pentapeptide onto the undecaprenyl phosphate carrier lipid,
Lipid II. Due to the critical nature of this protein, it has been considered as a prime target
for therapeutic agents. In the msa mutant, the expression mraY was down by 2.3-fold
(Figure 4.14), however, in the presence of oxacillin, the expression of mraY was similar
to wild type levels (Figure 4.15) It is possible that Msa, a putative membrane protein,
could be involved in sending signals into the cell for increased or decreased transcription
of mraY depending on the environmental conditions. Or the effect seen with mraY could
be an indirect result of the perturbation in Msa.
Penicillin-binding proteins (Pbp1, 2, 3 and 4) are involved in the construction and
cross-linking of the peptidoglycan layer. Pbp1 is an essential PBP that is involved in cell
division process (117, 120, 152). Pbp2 is a bifunctional PBP that conducts both
transpeptidase and ȕ-lactam-insensitive transglycosylase activities (91, 120). Penicillinbinding protein 3 and Pbp4 are not essential for growth (76, 120, 158). Inactivation of
Pbp3 does not cause any changes in the cell wall composition, nor does it affect the
growth rate. It was concluded that Pbp1 might be taking over the role of Pbp3, thus
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accounting for the lack of phenotypic alterations (49, 118, 120). RT-qPCR analysis
revealed that in the msa mutant samples collected from non-oxacillin-induced growth
conditions, the pbp genes were all expressed in amounts similar to that of the wild type
strain (Figure 4.17). Under oxacillin-induced conditions, however, all but pbp4 were
expressed in amounts similar to wild type (Figure 4.18). pbp4 was expressed more than
2-fold in the msa mutant in comparison to the wild type. Recent studies have shown that
a functioning Pbp4 is essential for the full expression Pbp2 when community-acquired
MRSA (CA-MRSA) were challenged with oxacillin (103). It is possible that this Pbp4
requirement is not specific to CA-MRSA strains, since MRSA strain COL used in this
study is a HA-MRSA strain. Apart from the explainable increase seen with the expression
of pbp4, the mutation of msa does not appear to play a role in the expression of genes
encoding for penicillin-binding proteins.
All genes (tested under both oxacillin-induced and uninduced conditions) that had
a relative fold change of 2-fold or higher have been summarized in a graphical format in
Figure 4.19. From this data, it is evident that the mutation of msa possibly affects a wide
range of genes involved in cell wall synthesis, cell wall precursor synthesis and stress
response genes.
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Figure 4.16. Triton X-100 induced lytic assay. The msa mutant (closed triangle) in the
presence of Triton X-100 had increased lysis in comparison to the wild type strain COL
(closed diamonds). The complemented msa mutant (closed circle) had an intermediate
rate of lysis. Open symbols represent the respective strains used as a control without
Triton X-100 treatment. The values presented here are an average of two independent
runs with two technical replicates within each.
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Figure 4.17. Relative gene expression analysis of the pbp genes in the msa mutant vs. wild type strain COL.
Fold change values are an average of two independent runs. Two-fold decrease in fold change is indicated
with a red dashed line and a two-fold increase in fold change is indicated with a green dashed line where
applicable.
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Figure 4.18. Relative gene expression analysis of the pbp genes in the msa mutant vs. wild type strain COL.
Fold change values are an average of two independent runs. Two-fold decrease in fold change is indicated
with a red dashed line and a two-fold increase in fold change is indicated with a green dashed line where
applicable.

87

Figure 4.19. Relative gene expression analysis of the genes showing significant differences in the msa mutant vs.
wild type strain COL. Fold change values are an average of two independent runs. Two-fold decrease in fold
change is indicated with a red dashed line and a two-fold increase in fold change is indicated with a green dashed
line where applicable.
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Conclusion
Msa was predicted to be a membrane protein with three transmembrane domains
that contained phosphorylation and binding sites (Figure 2.2). This suggested that Msa
might interact with the external environment (108) and act as a sensor for an external
signal that modulates sarA expression and thereby regulates the expression of several S.
aureus virulence factor (130). Disrupting the msa gene caused a drastic decrease in
antibiotic resistance levels of a homogenously resistant MRSA strain. Phenotypic and
RT-qPCR results from this study have shown that msa regulates the expression of several
chromosomally encoded genes that are involved in methicillin resistance. Also, it appears
that the msa mutant is unable to form a proper cell wall and is further challenged upon
addition of oxacillin. Thus, msa is a major regulator of antibiotic resistance in
methicillin-resistant Staphylococcus aureus (MRSA). The mecA gene, whose protein
product, Pbp2a, is primarily responsible for the MRSA phenotype, appears to also be
regulated by Msa. However, the fact that msa regulates the expression of several
chromosomally encoded cell wall synthesis and cell wall synthesis precursor genes
makes it a promising target for future antibiotic therapies. Msa positively regulates the
expression of sarA (130), a global regulator that controls the expression of over 100
genes. It is possible that other antibiotic-resistance-related genes are also regulated by
msa, either via sarA or independent of sarA.
In order to further understand the global role of Msa in S. aureus, a DNA
microarray analysis was conducted using samples exposed to oxacillin. Results from the
initial assessment of the differentially expressed genes that were three-fold or higher are
summarized in Tables 4.7 and 4.8. Further analysis of the microarray data using RT-
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qPCR and validation with functional assays will help in understanding the true potential
of msa as a target for therapy. Among other genes, major global regulators such as the
agr system appear to be upregulated by Msa (Table 4.7) in the transcriptome analysis.
Further studies are necessary, however, to assess the synergistic role of agr and msa in
antibiotic resistance of Methicillin-Resistant Staphlyococcus aureus strains.
Based on the current knowledge regarding msa, it is proposed here that Msa is
possibly a membrane protein that regulates genes that are involved in biofilm formation,
antibiotic resistance mechanisms and global virulence regulation (Figure 4.20). The
multi-faceted and evidently vital role of Msa suggests that it could be an attractive
candidate for future anti-virulence therapies against Staphylococcus aureus.

Figure 4.20. Msa, a putative membrane protein, is involved in regulating antibiotic
resistance, biofilm formation and virulence factors either via sarA or independently.
Table 4.7
List of Genes Downregulated in the msa Mutant in Comparison to Wild Type
ORF1
SA1589
SA0029
SAS066
SAS067
SA2260
SA0040

Mean

Gene

Gene Function

6.919
6.567
4.883
4.700
4.562
4.436

ribD
pre
agrD
agrB
fabG2
mecI

riboflavin specific deaminase
plasmid recombination enzyme
accessory gene regulator protein D
accessory gene regulator protein B
3-oxoacyl-(acyl carrier protein) reductase
methicillin resistance regulatory protein
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Table 4.7 (continued).
ORF1

Mean Gene

SA1339

4.427 malR

SA1092
SA1204
SAS068
SA0655
SA1515
SA2336
SA1984
SA2428

SA0185

SA0041
SA1701
SA0597
SA0109

Gene Function

maltose operon transcriptional repressor
cell division protein FtsZ; similar structure to tubulin; forms
4.382 ftsZ
ring-shaped polymers at the site of cell division
tryptophan synthase subunit beta; catalyzes the formation of L4.251 trpB
tryptophan from L-serine and 1-(indol-3-yl)glycerol 3-phosphate
4.224 agrC2 accessory gene regulator protein C
4.105 fruA
fructose specific permease
4.012 phoR alkaline phosphatase synthesis sensor protein
3.819 clpL
ATP-dependent Clp proteinase chain clpL
3.810 asp23 alkaline shock protein 23
arginine deiminase; catalyzes the degradation of arginine to
3.738 arcA
citruline and ammonia
N-acetylmuramic acid-6-phosphate etherase; catalyzes the
cleavage of the lactyl ether moiety of N-acetylmuramic acid-6murQ,
3.651
phosphate (MurNAc-6-P) to form N-acetylglucosamine-6yfeU
phosphate (GlcNAc-6-P) and lactate; MurNAc dissimilation
pathway
3.521 xylR
hypothetical protein; xylose repressor homologue
3.452 vraS
two-component sensor histidine kinase
3.418 tagD
glycerol-3-phosphate cytidylyltransferase; next to pbp4
3.381 sirC
iron compound ABC transporter, permease protein

Note: 1 ORF IDs are mapped to N315 locus when available.

Table 4.8
List of Genes Upregulated in the msa Mutant in Comparison to Wild Type
ORF1
SA1988
SA0107
SA0667
SA1614
SA0400
SA1586
SA1629
SA1818
SA1372
SA0108
SA0053
SA0204
MW759

Mean
3.051
3.208
3.261
3.348
3.687
3.741
4.046
4.107
4.229
4.285
4.344
5.714
9.556

Gene Gene Function
modC
spa
exsB
menC
lpl4
ribH
splC

molybdenum transport ATP-binding protein ModC
immunoglobulin G binding protein A precursor
ExsB protein; identified by protein match
o-succinylbenzoic acid synthetase
hypothetical protein
6,7-diimethyl-8-ribityllumazine synthase; DMRL synthase
serine protease SplC
hypothetical protein; similar to beta-lactamase
comG ComG operon protein 3 precursor
sarS
Staphylococcal accessory regulator S
radC hypothetical protein, similar to DNA repair protein
acpD azoreductase; cleaves azo bond in aromatic azo compounds
sec4
enterotoxin type C precursor

Note: 1 ORF IDs are mapped to N315 locus when available.
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